{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Dependencies\n",
    "from bs4 import BeautifulSoup\n",
    "import requests\n",
    "import re\n",
    "import pandas as pd\n",
    "import time"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# URL of page to be scraped\n",
    "url = 'http://www.centuryclinical.com/sponsors.html'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Retrieve page with the requests module\n",
    "response = requests.get(url)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Create BeautifulSoup object; parse with 'html.parser'\n",
    "soup = BeautifulSoup(response.text, 'html.parser')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<html>\n",
      " <head>\n",
      "  <title>\n",
      "   Century Clinical Research - Sponsors\n",
      "  </title>\n",
      "  <meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n",
      "  <link href=\"/stylesheets/master.css\" rel=\"stylesheet\" type=\"text/css\"/>\n",
      "  <link href=\"/stylesheets/master_century_clinical_research.css\" rel=\"stylesheet\" type=\"text/css\"/>\n",
      "  <script src=\"/javascript/jquery-1.3.2.js\" type=\"text/javascript\">\n",
      "  </script>\n",
      "  <script src=\"/javascript/flash_green.js\" type=\"text/javascript\">\n",
      "  </script>\n",
      "  <script src=\"/javascript/home_green.js\" type=\"text/javascript\">\n",
      "  </script>\n",
      "  <script src=\"/javascript/home_green_right.js\" type=\"text/javascript\">\n",
      "  </script>\n",
      "  <script src=\"/javascript/swfobject.js\" type=\"text/javascript\">\n",
      "  </script>\n",
      "  <script src=\"/javascript/jquery.cycle.all.js\" type=\"text/javascript\">\n",
      "  </script>\n",
      "  <script type=\"text/javascript\">\n",
      "   flashVars=new Object();\r\n",
      "\t\tflashVars.piclist = \"/images/tempflash/sponsors/sponsors_1.jpg,/images/tempflash/sponsors/sponsors_2.jpg,/images/tempflash/sponsors/sponsors_3.jpg\";\r\n",
      "\t\tflashVars.textlist = \"Making a Difference,Making a Difference,Making a Difference\";\r\n",
      "\t\tswfobject.embedSWF(\"contentImages/flash/pics.swf\", \"flashdiv\", \"587\", \"206\", \"9.0.0\", \"/javascript/expressInstall.swf\",flashVars);\n",
      "  </script>\n",
      "  <style type=\"text/css\">\n",
      "   .slideshow { height: 206px; width: 282px;}\r\n",
      ".slideshow img {border: 0; background-color: #FFFFFF; }\n",
      "  </style>\n",
      "  <!-- include jQuery library -->\n",
      "  <script src=\"/javascript/jquery-1.3.2.js\" type=\"text/javascript\">\n",
      "  </script>\n",
      "  <!-- include Cycle plugin -->\n",
      "  <script src=\"/javascript/jquery.cycle.all.js\" type=\"text/javascript\">\n",
      "  </script>\n",
      "  <script type=\"text/javascript\">\n",
      "   $(document).ready(function() {\r\n",
      "    $('.slideshow').cycle({\r\n",
      "\t\tfx: 'fade' // choose your transition type, ex: fade, scrollUp, shuffle, etc...\r\n",
      "\t});\r\n",
      "});\n",
      "  </script>\n",
      " </head>\n",
      " <body id=\"p_landSponsorsResearch\">\n",
      "  <div id=\"wrap\">\n",
      "   <div id=\"wrap1\">\n",
      "    <div id=\"head\" style=\"position:relative; top:0; left:0;\">\n",
      "     <ul id=\"navVERSION\">\n",
      "      <li id=\"research\">\n",
      "       <a href=\"century_clinical_research.html\">\n",
      "        Century Clinical Research\n",
      "       </a>\n",
      "      </li>\n",
      "      <li id=\"family\">\n",
      "       <a href=\"century_clinical_family_practice.html\">\n",
      "        Century Clinical Family Research\n",
      "       </a>\n",
      "      </li>\n",
      "     </ul>\n",
      "     <div style=\"position:absolute; top:55px; right:20px;\">\n",
      "      <a href=\"http://centuryclinical.leapfile.net\" style=\"color: #FFFFFF; background: #002A5C; padding: 0.4em 1em; text-decoration: none; margin-right: 10px; position: relative; top: -8px;\" target=\"_blank\" title=\"Send to records@centuryclinical.com\">\n",
      "       Secure File Upload\n",
      "      </a>\n",
      "      <a href=\"http://www.facebook.com/pages/Century-Clinical-Research-Inc/243722359020276\" onclick=\"window.open(this.href); return false;\">\n",
      "       <img alt=\"Facebook\" src=\"/contentImages/default/facebookIcon.png\"/>\n",
      "      </a>\n",
      "     </div>\n",
      "    </div>\n",
      "    <div id=\"p_sponsors\">\n",
      "     <ul class=\"clearfix\" id=\"navMAIN\">\n",
      "      <li id=\"display_date\">\n",
      "       Monday, February 18, 2019\n",
      "      </li>\n",
      "      <li id=\"blue\">\n",
      "       <a href=\"century_clinical_research.html\">\n",
      "        Volunteers\n",
      "       </a>\n",
      "      </li>\n",
      "      <li id=\"green\">\n",
      "       <a href=\"sponsors.html\">\n",
      "        Sponsors\n",
      "       </a>\n",
      "      </li>\n",
      "      <li id=\"brown\">\n",
      "       <a href=\"about_ccri.html\">\n",
      "        About CCRI\n",
      "       </a>\n",
      "      </li>\n",
      "     </ul>\n",
      "    </div>\n",
      "    <div id=\"content\">\n",
      "     <ul class=\"clearfix\" id=\"contentSubNAV\">\n",
      "      <li>\n",
      "       <a href=\"sponsors.html\">\n",
      "        Sponsors\n",
      "       </a>\n",
      "      </li>\n",
      "     </ul>\n",
      "     <div class=\"clearfix\" id=\"content1\">\n",
      "      <div id=\"flashwrapper\">\n",
      "       <div id=\"flashdiv\">\n",
      "        <img alt=\"flash\" height=\"206\" id=\"flashPlaceHolder\" src=\"/contentImages/default/img_flashPlaceholder_sponsors.jpg\" width=\"587\"/>\n",
      "       </div>\n",
      "      </div>\n",
      "      <div class=\"slideshow\">\n",
      "       <img height=\"206\" src=\"contentImages/default/safe.gif\" width=\"282\"/>\n",
      "       <img height=\"206\" src=\"contentImages/default/accurate.gif\" width=\"282\"/>\n",
      "       <img height=\"206\" src=\"contentImages/default/reliable.gif\" width=\"282\"/>\n",
      "      </div>\n",
      "      <div class=\"clearfix\" id=\"content2\">\n",
      "       <div id=\"Lcol\">\n",
      "        <h1>\n",
      "         Clinical Trial Sponsors\n",
      "        </h1>\n",
      "        <p>\n",
      "         Clinical trials are sponsored or funded by a variety of organizations or individuals. They can be sponsored by doctors, medical institutions, foundations, voluntary groups, pharmaceutical companies, or federal agencies such as the National Institutes of Health, or NIH.\n",
      "        </p>\n",
      "        <p>\n",
      "         The following is a partial list of clinical trial sponsors with whom Century Clinical Research has worked.\n",
      "        </p>\n",
      "        <table border=\"0\">\n",
      "         <tbody>\n",
      "          <tr>\n",
      "           <td>\n",
      "            <ul class=\"content_list_sponsors\">\n",
      "             <li>\n",
      "              3M\n",
      "             </li>\n",
      "             <li>\n",
      "              Abbott Laboratories\n",
      "             </li>\n",
      "             <li>\n",
      "              Altana\n",
      "             </li>\n",
      "             <li>\n",
      "              Alteon\n",
      "             </li>\n",
      "             <li>\n",
      "              Alza\n",
      "             </li>\n",
      "             <li>\n",
      "              Amgen Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Amylin Corporation\n",
      "             </li>\n",
      "             <li>\n",
      "              Andrx\n",
      "             </li>\n",
      "             <li>\n",
      "              Astra Merck\n",
      "             </li>\n",
      "             <li>\n",
      "              Astra Pharmaceuticals\n",
      "             </li>\n",
      "             <li>\n",
      "              Astra Zeneca\n",
      "             </li>\n",
      "             <li>\n",
      "              Aura Laboratories, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Aventis\n",
      "             </li>\n",
      "             <li>\n",
      "              Barr\n",
      "             </li>\n",
      "             <li>\n",
      "              Bayer Corporation\n",
      "             </li>\n",
      "             <li>\n",
      "              Berlix\n",
      "             </li>\n",
      "             <li>\n",
      "              Biovail Technologies Ltd.\n",
      "             </li>\n",
      "             <li>\n",
      "              Boehringer Ingelheim\n",
      "             </li>\n",
      "             <li>\n",
      "              Bristol-Myers Squibb\n",
      "             </li>\n",
      "             <li>\n",
      "              Byk Gulden\n",
      "             </li>\n",
      "             <li>\n",
      "              Cipher\n",
      "             </li>\n",
      "             <li>\n",
      "              Covalent Research Alliance\n",
      "             </li>\n",
      "             <li>\n",
      "              DepoMed\n",
      "             </li>\n",
      "             <li>\n",
      "              Duramed\n",
      "             </li>\n",
      "             <li>\n",
      "              Eisai\n",
      "             </li>\n",
      "             <li>\n",
      "              Entropin\n",
      "             </li>\n",
      "             <li>\n",
      "              Eli Lilly &amp; Co.\n",
      "             </li>\n",
      "             <li>\n",
      "              Fisons\n",
      "             </li>\n",
      "             <li>\n",
      "              Forest Labs\n",
      "             </li>\n",
      "             <li>\n",
      "              G. D. Searle Pharmaceuticals\n",
      "             </li>\n",
      "             <li>\n",
      "              Genaissance\n",
      "             </li>\n",
      "             <li>\n",
      "              Genentech, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Glaxo-Wellcome\n",
      "             </li>\n",
      "             <li>\n",
      "              GlaxoSmithKline\n",
      "             </li>\n",
      "             <li>\n",
      "              Hoechst Marion Roussel\n",
      "             </li>\n",
      "             <li>\n",
      "              Hoffman LaRoche\n",
      "             </li>\n",
      "             <li>\n",
      "              Johnson &amp; Johnson\n",
      "             </li>\n",
      "             <li>\n",
      "              Knoll Pharmaceutical Company\n",
      "              <ul>\n",
      "              </ul>\n",
      "             </li>\n",
      "            </ul>\n",
      "           </td>\n",
      "           <td>\n",
      "            <ul class=\"content_list_sponsors\">\n",
      "             <li>\n",
      "              Medivir\n",
      "             </li>\n",
      "             <li>\n",
      "              Merck Human Health Division\n",
      "             </li>\n",
      "             <li>\n",
      "              Merck Research Laboratories\n",
      "             </li>\n",
      "             <li>\n",
      "              Mitsubishi\n",
      "             </li>\n",
      "             <li>\n",
      "              NiCox\n",
      "             </li>\n",
      "             <li>\n",
      "              Novartis\n",
      "             </li>\n",
      "             <li>\n",
      "              Novo Nordisk\n",
      "             </li>\n",
      "             <li>\n",
      "              NPS\n",
      "             </li>\n",
      "             <li>\n",
      "              ObeCureo Ortho-McNeil Pharmaceuticals, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Parke-Davis Pharmaceuticals\n",
      "             </li>\n",
      "             <li>\n",
      "              Pfizer, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              PPD\n",
      "             </li>\n",
      "             <li>\n",
      "              Pharmacia &amp; Upjohn\n",
      "             </li>\n",
      "             <li>\n",
      "              Preventive Medical Technologies\n",
      "             </li>\n",
      "             <li>\n",
      "              Purdue Pharma\n",
      "             </li>\n",
      "             <li>\n",
      "              Radius Health, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Regeneron\n",
      "             </li>\n",
      "             <li>\n",
      "              Roche Laboratories\n",
      "             </li>\n",
      "             <li>\n",
      "              R.W. Johnson Pharmaceutical Research Institute\n",
      "             </li>\n",
      "             <li>\n",
      "              Rhone-Poulenc Rorer\n",
      "             </li>\n",
      "             <li>\n",
      "              Sankyo, USA\n",
      "             </li>\n",
      "             <li>\n",
      "              Sanofi-Synthelabo\n",
      "             </li>\n",
      "             <li>\n",
      "              Schering Plough\n",
      "             </li>\n",
      "             <li>\n",
      "              Searle\n",
      "             </li>\n",
      "             <li>\n",
      "              Sepracor, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Smith-Klein Beecham\n",
      "             </li>\n",
      "             <li>\n",
      "              Solvay Pharmaceuticals Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Takeda America, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              TAP Holdings, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Therimmune\n",
      "             </li>\n",
      "             <li>\n",
      "              Transport\n",
      "             </li>\n",
      "             <li>\n",
      "              Tularik\n",
      "             </li>\n",
      "             <li>\n",
      "              Upsher-Smith\n",
      "             </li>\n",
      "             <li>\n",
      "              Vector\n",
      "             </li>\n",
      "             <li>\n",
      "              Watson\n",
      "             </li>\n",
      "             <li>\n",
      "              Winston\n",
      "             </li>\n",
      "             <li>\n",
      "              Wyeth Ayerst\n",
      "             </li>\n",
      "             <li>\n",
      "              Zeneca Pharmaceuticals\n",
      "             </li>\n",
      "            </ul>\n",
      "           </td>\n",
      "          </tr>\n",
      "         </tbody>\n",
      "        </table>\n",
      "       </div>\n",
      "       <div id=\"Rcol\">\n",
      "        <h1>\n",
      "         Clinical Research Organizations\n",
      "        </h1>\n",
      "        <p>\n",
      "         A Contract Research Organization, also called a Clinical Research Organization, (CRO) is a service organization that provides support to the pharmaceutical/biotech industry. CROs offer clients a wide range of outsourced pharmaceutical research services to aid in the drug and medical device research and development process. They assume one or more obligations of a clinical trial sponsor, e.g., design of a protocol, selection or monitoring of investigations, evaluation of reports, and preparation of materials to be submitted to the Food and Drug Administration.\n",
      "        </p>\n",
      "        <p>\n",
      "         The following is a partial list of contract research organizations with whom Century Clinical Research has worked.\n",
      "        </p>\n",
      "        <table border=\"0\">\n",
      "         <tbody>\n",
      "          <tr>\n",
      "           <td>\n",
      "            <ul class=\"content_list_sponsors\">\n",
      "             <li>\n",
      "              Acurian\n",
      "             </li>\n",
      "             <li>\n",
      "              Advanced Biologics\n",
      "             </li>\n",
      "             <li>\n",
      "              Barton and Polansky\n",
      "             </li>\n",
      "             <li>\n",
      "              BioPharm\n",
      "             </li>\n",
      "             <li>\n",
      "              Celeris\n",
      "             </li>\n",
      "             <li>\n",
      "              Clinimetrics Research Associates\n",
      "             </li>\n",
      "             <li>\n",
      "              ClinTrials, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Concepts in Pharmaceutical Research (CPR)\n",
      "             </li>\n",
      "             <li>\n",
      "              Covalent Research Alliance, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Covance\n",
      "             </li>\n",
      "             <li>\n",
      "              Global IQ\n",
      "             </li>\n",
      "             <li>\n",
      "              IBRD/Phoenix\n",
      "             </li>\n",
      "             <li>\n",
      "              ICON\n",
      "             </li>\n",
      "            </ul>\n",
      "           </td>\n",
      "           <td>\n",
      "            <ul class=\"content_list_sponsors\">\n",
      "             <li>\n",
      "              INC Research\n",
      "             </li>\n",
      "             <li>\n",
      "              Ingenix\n",
      "             </li>\n",
      "             <li>\n",
      "              Innove Integrated Research\n",
      "             </li>\n",
      "             <li>\n",
      "              Kendle International\n",
      "             </li>\n",
      "             <li>\n",
      "              MedPace\n",
      "             </li>\n",
      "             <li>\n",
      "              MTRA\n",
      "             </li>\n",
      "             <li>\n",
      "              Omnicare\n",
      "             </li>\n",
      "             <li>\n",
      "              Paragon Biomedical, Inc.\n",
      "             </li>\n",
      "             <li>\n",
      "              Parexel International Corporation\n",
      "             </li>\n",
      "             <li>\n",
      "              Pharmaceutical C-Trials\n",
      "             </li>\n",
      "             <li>\n",
      "              Pharmaceutical Research Associates (PRA)\n",
      "             </li>\n",
      "             <li>\n",
      "              PharmaResearch\n",
      "             </li>\n",
      "             <li>\n",
      "              PPD Pharmaco\n",
      "             </li>\n",
      "            </ul>\n",
      "           </td>\n",
      "          </tr>\n",
      "         </tbody>\n",
      "        </table>\n",
      "        <p>\n",
      "        </p>\n",
      "        <h2>\n",
      "         Institutional Review Boards\n",
      "        </h2>\n",
      "        <p>\n",
      "         CCRI has access to local hospital IRBs’ for inpatient studies and have used the following Central Institutional Review Boards (IRB’s) for outpatient studies:  SAIRB, WIRB, NEIRB, Quorum, Copernicus, Coast and Chesapeake .\n",
      "        </p>\n",
      "       </div>\n",
      "      </div>\n",
      "     </div>\n",
      "    </div>\n",
      "    <div id=\"footer\">\n",
      "     <div style=\"float: left; padding: 20px 0;\">\n",
      "      <p style=\"text-align: left;\">\n",
      "       ©2014 Century Clinical Research. All rights reserved.\n",
      "       <a href=\"clinical_performance.html\">\n",
      "        Privacy policy.\n",
      "       </a>\n",
      "      </p>\n",
      "     </div>\n",
      "     <div style=\"float: right; padding: 20px 0;\">\n",
      "     </div>\n",
      "     <div style=\"clear: both;\">\n",
      "     </div>\n",
      "    </div>\n",
      "   </div>\n",
      "  </div>\n",
      " </body>\n",
      "</html>\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Examine the results, then determine element that contains sought info\n",
    "print(soup.prettify())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[<ul class=\"content_list_sponsors\">\n",
      "<li>3M</li>\n",
      "<li>Abbott Laboratories</li>\n",
      "<li>Altana</li>\n",
      "<li>Alteon</li>\n",
      "<li>Alza</li>\n",
      "<li>Amgen Inc.</li>\n",
      "<li>Amylin Corporation</li>\n",
      "<li>Andrx</li>\n",
      "<li>Astra Merck</li>\n",
      "<li>Astra Pharmaceuticals</li>\n",
      "<li>Astra Zeneca</li>\n",
      "<li>Aura Laboratories, Inc.</li>\n",
      "<li>Aventis</li>\n",
      "<li>Barr</li>\n",
      "<li>Bayer Corporation</li>\n",
      "<li>Berlix</li>\n",
      "<li>Biovail Technologies Ltd.</li>\n",
      "<li>Boehringer Ingelheim</li>\n",
      "<li>Bristol-Myers Squibb</li>\n",
      "<li>Byk Gulden</li>\n",
      "<li>Cipher</li>\n",
      "<li>Covalent Research Alliance</li>\n",
      "<li>DepoMed</li>\n",
      "<li>Duramed</li>\n",
      "<li>Eisai</li>\n",
      "<li>Entropin</li>\n",
      "<li>Eli Lilly &amp; Co.</li>\n",
      "<li>Fisons</li>\n",
      "<li>Forest Labs</li>\n",
      "<li>G. D. Searle Pharmaceuticals</li>\n",
      "<li>Genaissance</li>\n",
      "<li>Genentech, Inc.</li>\n",
      "<li>Glaxo-Wellcome</li>\n",
      "<li>GlaxoSmithKline</li>\n",
      "<li>Hoechst Marion Roussel</li>\n",
      "<li>Hoffman LaRoche</li>\n",
      "<li>Johnson &amp; Johnson</li>\n",
      "<li>Knoll Pharmaceutical Company  \r\n",
      "<ul>\n",
      "</ul>\n",
      "</li>\n",
      "</ul>, <ul class=\"content_list_sponsors\">\n",
      "<li>Medivir</li>\n",
      "<li>Merck Human Health Division</li>\n",
      "<li>Merck Research Laboratories</li>\n",
      "<li>Mitsubishi</li>\n",
      "<li>NiCox</li>\n",
      "<li>Novartis</li>\n",
      "<li>Novo Nordisk</li>\n",
      "<li>NPS</li>\n",
      "<li>ObeCureo Ortho-McNeil Pharmaceuticals, Inc.</li>\n",
      "<li>Parke-Davis Pharmaceuticals</li>\n",
      "<li>Pfizer, Inc.</li>\n",
      "<li>PPD</li>\n",
      "<li>Pharmacia &amp; Upjohn</li>\n",
      "<li>Preventive Medical Technologies</li>\n",
      "<li>Purdue Pharma</li>\n",
      "<li>Radius Health, Inc.</li>\n",
      "<li>Regeneron</li>\n",
      "<li>Roche Laboratories</li>\n",
      "<li>R.W. Johnson Pharmaceutical Research Institute</li>\n",
      "<li>Rhone-Poulenc Rorer</li>\n",
      "<li>Sankyo, USA</li>\n",
      "<li>Sanofi-Synthelabo</li>\n",
      "<li>Schering Plough</li>\n",
      "<li>Searle</li>\n",
      "<li>Sepracor, Inc.</li>\n",
      "<li>Smith-Klein Beecham</li>\n",
      "<li>Solvay Pharmaceuticals Inc.</li>\n",
      "<li>Takeda America, Inc.</li>\n",
      "<li>TAP Holdings, Inc.</li>\n",
      "<li>Therimmune</li>\n",
      "<li>Transport</li>\n",
      "<li>Tularik</li>\n",
      "<li>Upsher-Smith</li>\n",
      "<li>Vector</li>\n",
      "<li>Watson</li>\n",
      "<li>Winston</li>\n",
      "<li>Wyeth Ayerst</li>\n",
      "<li>Zeneca Pharmaceuticals</li>\n",
      "</ul>, <ul class=\"content_list_sponsors\">\n",
      "<li>Acurian</li>\n",
      "<li>Advanced Biologics</li>\n",
      "<li>Barton and Polansky</li>\n",
      "<li>BioPharm</li>\n",
      "<li>Celeris</li>\n",
      "<li>Clinimetrics Research Associates</li>\n",
      "<li>ClinTrials, Inc.</li>\n",
      "<li>Concepts in Pharmaceutical Research (CPR)</li>\n",
      "<li>Covalent Research Alliance, Inc.</li>\n",
      "<li>Covance</li>\n",
      "<li>Global IQ</li>\n",
      "<li>IBRD/Phoenix</li>\n",
      "<li>ICON</li>\n",
      "</ul>, <ul class=\"content_list_sponsors\">\n",
      "<li>INC Research</li>\n",
      "<li>Ingenix</li>\n",
      "<li>Innove Integrated Research</li>\n",
      "<li>Kendle International</li>\n",
      "<li>MedPace</li>\n",
      "<li>MTRA</li>\n",
      "<li>Omnicare</li>\n",
      "<li>Paragon Biomedical, Inc.</li>\n",
      "<li>Parexel International Corporation</li>\n",
      "<li>Pharmaceutical C-Trials</li>\n",
      "<li>Pharmaceutical Research Associates (PRA)</li>\n",
      "<li>PharmaResearch</li>\n",
      "<li>PPD Pharmaco</li>\n",
      "</ul>]\n"
     ]
    }
   ],
   "source": [
    "# results are returned as an iterable list\n",
    "results = soup.find_all('ul', class_=\"content_list_sponsors\")\n",
    "print(results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "4\n",
      "{'Sponsors': ['Medivir', 'Merck Human Health Division', 'Merck Research Laboratories', 'Mitsubishi', 'NiCox', 'Novartis', 'Novo Nordisk', 'NPS', 'ObeCureo Ortho-McNeil Pharmaceuticals, Inc.<', 'Parke-Davis Pharmaceuticals', 'Pfizer, Inc.', 'PPD', 'Pharmacia &amp; Upjohn', 'Preventive Medical Technologies', 'Purdue Pharma', 'Radius Health, Inc.', 'Regeneron', 'Roche Laboratories', 'R.W. Johnson Pharmaceutical Research Institu', 'Rhone-Poulenc Rorer', 'Sankyo, USA', 'Sanofi-Synthelabo', 'Schering Plough', 'Searle', 'Sepracor, Inc.', 'Smith-Klein Beecham', 'Solvay Pharmaceuticals Inc.', 'Takeda America, Inc.', 'TAP Holdings, Inc.', 'Therimmune', 'Transport', 'Tularik', 'Upsher-Smith', 'Vector', 'Watson', 'Winston', 'Wyeth Ayerst', 'Zeneca Pharmaceuticals', 'Acurian', 'Advanced Biologics', 'Barton and Polansky', 'BioPharm', 'Celeris', 'Clinimetrics Research Associates', 'ClinTrials, Inc.', 'Concepts in Pharmaceutical Research (CP', 'Covalent Research Alliance, Inc.', 'Covance', 'Global IQ', 'IBRD/Phoenix', 'ICON', 'INC Research', 'Ingenix', 'Innove Integrated Research', 'Kendle International', 'MedPace', 'MTRA', 'Omnicare', 'Paragon Biomedical, Inc.', 'Parexel International Corporation', 'Pharmaceutical C-Trials', 'Pharmaceutical Research Associates (PRA', 'PharmaResearch', 'PPD Pharmaco']}\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sponsors</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Medivir</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Merck Human Health Division</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Merck Research Laboratories</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Mitsubishi</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NiCox</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                      Sponsors\n",
       "0                      Medivir\n",
       "1  Merck Human Health Division\n",
       "2  Merck Research Laboratories\n",
       "3                   Mitsubishi\n",
       "4                        NiCox"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sponsors=[]\n",
    "print(len(results))\n",
    "for i in range(1, len(results)):\n",
    "#     print(results[i])\n",
    "    for ul in results[i]:\n",
    "#         print(ul)\n",
    "        if (re.search(\"^<li>.*</li>$\", str(ul) )):\n",
    "            sponsor = re.sub('</li>','',re.sub('<li>','',str(re.search(\"^<li>.*</li>$\", str(ul) ))))\n",
    "            sponsors.append(sponsor[39:-2])            \n",
    "# print(sponsors)\n",
    "sponsors_dict = {'Sponsors':sponsors}\n",
    "print(sponsors_dict)\n",
    "df_sponsors = pd.DataFrame(data=sponsors_dict)\n",
    "df_sponsors.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sponsors</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>Acurian</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>Advanced Biologics</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>Barton and Polansky</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>BioPharm</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>Celeris</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>ClinTrials, Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>Clinimetrics Research Associates</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>Concepts in Pharmaceutical Research (CP</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>Covalent Research Alliance, Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>Covance</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Global IQ</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>IBRD/Phoenix</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>ICON</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>INC Research</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>Ingenix</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Innove Integrated Research</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>Kendle International</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>MTRA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>MedPace</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Medivir</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Merck Human Health Division</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Merck Research Laboratories</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Mitsubishi</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NPS</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NiCox</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Novartis</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Novo Nordisk</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>ObeCureo Ortho-McNeil Pharmaceuticals, Inc.&lt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>Omnicare</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>PPD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Pfizer, Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>PharmaResearch</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>Pharmaceutical C-Trials</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>Pharmaceutical Research Associates (PRA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Pharmacia &amp;amp; Upjohn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Preventive Medical Technologies</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Purdue Pharma</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>R.W. Johnson Pharmaceutical Research Institu</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>Radius Health, Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Regeneron</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Rhone-Poulenc Rorer</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>Roche Laboratories</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>Sankyo, USA</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>Sanofi-Synthelabo</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>Schering Plough</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>Searle</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>Sepracor, Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>Smith-Klein Beecham</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>Solvay Pharmaceuticals Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>TAP Holdings, Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Takeda America, Inc.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>Therimmune</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>Transport</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>Tularik</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>Upsher-Smith</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>Vector</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>Watson</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>Winston</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>Wyeth Ayerst</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>Zeneca Pharmaceuticals</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>64 rows × 1 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        Sponsors\n",
       "38                                       Acurian\n",
       "39                            Advanced Biologics\n",
       "40                           Barton and Polansky\n",
       "41                                      BioPharm\n",
       "42                                       Celeris\n",
       "44                              ClinTrials, Inc.\n",
       "43              Clinimetrics Research Associates\n",
       "45       Concepts in Pharmaceutical Research (CP\n",
       "46              Covalent Research Alliance, Inc.\n",
       "47                                       Covance\n",
       "48                                     Global IQ\n",
       "49                                  IBRD/Phoenix\n",
       "50                                          ICON\n",
       "51                                  INC Research\n",
       "52                                       Ingenix\n",
       "53                    Innove Integrated Research\n",
       "54                          Kendle International\n",
       "56                                          MTRA\n",
       "55                                       MedPace\n",
       "0                                        Medivir\n",
       "1                    Merck Human Health Division\n",
       "2                    Merck Research Laboratories\n",
       "3                                     Mitsubishi\n",
       "7                                            NPS\n",
       "4                                          NiCox\n",
       "5                                       Novartis\n",
       "6                                   Novo Nordisk\n",
       "8   ObeCureo Ortho-McNeil Pharmaceuticals, Inc.<\n",
       "57                                      Omnicare\n",
       "11                                           PPD\n",
       "..                                           ...\n",
       "10                                  Pfizer, Inc.\n",
       "62                                PharmaResearch\n",
       "60                       Pharmaceutical C-Trials\n",
       "61       Pharmaceutical Research Associates (PRA\n",
       "12                        Pharmacia &amp; Upjohn\n",
       "13               Preventive Medical Technologies\n",
       "14                                 Purdue Pharma\n",
       "18  R.W. Johnson Pharmaceutical Research Institu\n",
       "15                           Radius Health, Inc.\n",
       "16                                     Regeneron\n",
       "19                           Rhone-Poulenc Rorer\n",
       "17                            Roche Laboratories\n",
       "20                                   Sankyo, USA\n",
       "21                             Sanofi-Synthelabo\n",
       "22                               Schering Plough\n",
       "23                                        Searle\n",
       "24                                Sepracor, Inc.\n",
       "25                           Smith-Klein Beecham\n",
       "26                   Solvay Pharmaceuticals Inc.\n",
       "28                            TAP Holdings, Inc.\n",
       "27                          Takeda America, Inc.\n",
       "29                                    Therimmune\n",
       "30                                     Transport\n",
       "31                                       Tularik\n",
       "32                                  Upsher-Smith\n",
       "33                                        Vector\n",
       "34                                        Watson\n",
       "35                                       Winston\n",
       "36                                  Wyeth Ayerst\n",
       "37                        Zeneca Pharmaceuticals\n",
       "\n",
       "[64 rows x 1 columns]"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_sponsors.sort_values('Sponsors')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "https://clinicaltrials.gov/ct2/results?spons=Medivir\n",
      "https://clinicaltrials.gov/ct2/results?spons=Mitsubishi\n",
      "https://clinicaltrials.gov/ct2/results?spons=NiCox\n",
      "https://clinicaltrials.gov/ct2/results?spons=Novartis\n",
      "https://clinicaltrials.gov/ct2/results?spons=NPS\n",
      "https://clinicaltrials.gov/ct2/results?spons=PPD\n",
      "https://clinicaltrials.gov/ct2/results?spons=Regeneron\n",
      "https://clinicaltrials.gov/ct2/results?spons=Sanofi-Synthelabo\n",
      "https://clinicaltrials.gov/ct2/results?spons=Searle\n",
      "https://clinicaltrials.gov/ct2/results?spons=Transport\n",
      "https://clinicaltrials.gov/ct2/results?spons=Tularik\n",
      "https://clinicaltrials.gov/ct2/results?spons=Vector\n",
      "https://clinicaltrials.gov/ct2/results?spons=Watson\n",
      "https://clinicaltrials.gov/ct2/results?spons=BioPharm\n",
      "https://clinicaltrials.gov/ct2/results?spons=Covance\n",
      "https://clinicaltrials.gov/ct2/results?spons=ICON\n",
      "https://clinicaltrials.gov/ct2/results?spons=MedPace\n"
     ]
    }
   ],
   "source": [
    "urls=[]\n",
    "for sponsor in sponsors:\n",
    "    if sponsor in ['Medivir','Mitsubishi','Novartis','Sanofi-Synthelabo','Covance','Vector','BioPharm',\n",
    "                  'Watson','Tularik','Transport','Searle','Regeneron','PPD','NPS','NiCox','MedPace','ICON']:\n",
    "        \n",
    "        url = 'https://clinicaltrials.gov/ct2/results?spons='\n",
    "        url = f'{url}{sponsor}'\n",
    "        urls.append(url)\n",
    "        print(url)\n",
    "# 'Therimmune','Winston','Acurian','MTRA','Omnicare',"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "https://clinicaltrials.gov/ct2/results?spons=Medivir is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Medivir is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Mitsubishi is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Mitsubishi is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=NiCox is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=NiCox is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Novartis is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Novartis is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=NPS is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=NPS is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=PPD is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=PPD is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Regeneron is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Regeneron is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Sanofi-Synthelabo is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Sanofi-Synthelabo is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Searle is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Searle is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Transport is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Transport is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Tularik is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Tularik is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Vector is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Vector is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Watson is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Watson is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=BioPharm is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=BioPharm is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=Covance is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=Covance is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=ICON is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=ICON is completed\n",
      "https://clinicaltrials.gov/ct2/results?spons=MedPace is started\n",
      "https://clinicaltrials.gov/ct2/results?spons=MedPace is completed\n"
     ]
    }
   ],
   "source": [
    "for url in urls:\n",
    "    print(f'{url} is started')\n",
    "    time.sleep(2)\n",
    "    response = requests.get(url)\n",
    "    soup = BeautifulSoup(response.text,'lxml')\n",
    "    # tables = soup.find_all('table')\n",
    "    tables = soup.find('table', attrs={'class':'stripe row-border compact'})\n",
    "    table_rows = tables.find_all('tr')\n",
    "#     print(len(tables))\n",
    "#     print(tables)\n",
    "    l = []\n",
    "    dfs=[]\n",
    "    print(f'{url} is completed')\n",
    "    for tr in table_rows:\n",
    "        try:\n",
    "            \n",
    "            td = tr.find_all('td')\n",
    "            row = [tr.text for tr in td]\n",
    "            l.append(row)\n",
    "            df_data = pd.DataFrame(l)\n",
    "            df_data.drop(0,axis=1,inplace=True)\n",
    "            df_data.columns=['NCT Number','Status','Title','Conditions','Interventions','Study Type','Phases',\n",
    "                             'Sponsor/Collaborators','Funded Bys','Study Results','Acronym',\n",
    "                             'Outcome Measures','Gender','Age','Enrollment',\n",
    "                             'Study Designs','Other IDs','Start Date','Primary Completion Date','Completion Date',\n",
    "                             'First Posted','Results First Posted','Last Update Posted','Locations','Study Documents']\n",
    "            df_data.head(2)\n",
    "            dfs.append(df_data)\n",
    "    \n",
    "        except Exception as e:\n",
    "            print(e)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "61\n"
     ]
    }
   ],
   "source": [
    "print(len(dfs))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_all_sponsors = pd.concat(dfs)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Status</th>\n",
       "      <th>Title</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03630081</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Study of Cefepime-tazobactam (FEP-TAZ) in Comp...</td>\n",
       "      <td>Complicated Urinary Tract InfectionAcute Pyelo...</td>\n",
       "      <td>Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>WockhardtMedpace Finland OY</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>W-4282-301</td>\n",
       "      <td></td>\n",
       "      <td>July 25, 2019</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>August 14, 2018</td>\n",
       "      <td>February 15, 2019</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03630081</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Study of Cefepime-tazobactam (FEP-TAZ) in Comp...</td>\n",
       "      <td>Complicated Urinary Tract InfectionAcute Pyelo...</td>\n",
       "      <td>Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>WockhardtMedpace Finland OY</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>W-4282-301</td>\n",
       "      <td></td>\n",
       "      <td>July 25, 2019</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>August 14, 2018</td>\n",
       "      <td>February 15, 2019</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03815695</td>\n",
       "      <td>RecruitingNew</td>\n",
       "      <td>A SAD/MAD to Assess the Safety, Pharmacokineti...</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>Drug: FT-4202/PlaceboDrug: FT-4202</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Forma Therapeutics, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Sequ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4202-HVS-101</td>\n",
       "      <td></td>\n",
       "      <td>December 11, 2018</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Medpace Clinical Pharmacology UnitCincinnati, ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03630081</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Study of Cefepime-tazobactam (FEP-TAZ) in Comp...</td>\n",
       "      <td>Complicated Urinary Tract InfectionAcute Pyelo...</td>\n",
       "      <td>Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>WockhardtMedpace Finland OY</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>W-4282-301</td>\n",
       "      <td></td>\n",
       "      <td>July 25, 2019</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>August 14, 2018</td>\n",
       "      <td>February 15, 2019</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03815695</td>\n",
       "      <td>RecruitingNew</td>\n",
       "      <td>A SAD/MAD to Assess the Safety, Pharmacokineti...</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>Drug: FT-4202/PlaceboDrug: FT-4202</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Forma Therapeutics, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Sequ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4202-HVS-101</td>\n",
       "      <td></td>\n",
       "      <td>December 11, 2018</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Medpace Clinical Pharmacology UnitCincinnati, ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03687255</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Safety and Efficacy Study of Cefepime-AAI101 i...</td>\n",
       "      <td>Urinary Tract Infections</td>\n",
       "      <td>Drug: cefepime/AAI101 combinationDrug: Piperac...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>AllecraMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>AT-301</td>\n",
       "      <td></td>\n",
       "      <td>September 24, 2018</td>\n",
       "      <td>November 30, 2019</td>\n",
       "      <td>December 30, 2019</td>\n",
       "      <td>September 27, 2018</td>\n",
       "      <td>September 28, 2018</td>\n",
       "      <td></td>\n",
       "      <td>St. Josephs Clinical ResearchAnaheim, Californ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03630081</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Study of Cefepime-tazobactam (FEP-TAZ) in Comp...</td>\n",
       "      <td>Complicated Urinary Tract InfectionAcute Pyelo...</td>\n",
       "      <td>Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>WockhardtMedpace Finland OY</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>W-4282-301</td>\n",
       "      <td></td>\n",
       "      <td>July 25, 2019</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>August 14, 2018</td>\n",
       "      <td>February 15, 2019</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03815695</td>\n",
       "      <td>RecruitingNew</td>\n",
       "      <td>A SAD/MAD to Assess the Safety, Pharmacokineti...</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>Drug: FT-4202/PlaceboDrug: FT-4202</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Forma Therapeutics, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Sequ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4202-HVS-101</td>\n",
       "      <td></td>\n",
       "      <td>December 11, 2018</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Medpace Clinical Pharmacology UnitCincinnati, ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03687255</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Safety and Efficacy Study of Cefepime-AAI101 i...</td>\n",
       "      <td>Urinary Tract Infections</td>\n",
       "      <td>Drug: cefepime/AAI101 combinationDrug: Piperac...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>AllecraMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>AT-301</td>\n",
       "      <td></td>\n",
       "      <td>September 24, 2018</td>\n",
       "      <td>November 30, 2019</td>\n",
       "      <td>December 30, 2019</td>\n",
       "      <td>September 27, 2018</td>\n",
       "      <td>September 28, 2018</td>\n",
       "      <td></td>\n",
       "      <td>St. Josephs Clinical ResearchAnaheim, Californ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03680612</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Cefepime/AAI101 Phase 2 Study in Hospitalized ...</td>\n",
       "      <td>Urinary Tract Infections</td>\n",
       "      <td>Drug: Cefepime 1G - 2G / AAI101 0.5G - 0.75GDr...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>AllecraMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>AT-201</td>\n",
       "      <td></td>\n",
       "      <td>September 5, 2017</td>\n",
       "      <td>February 14, 2018</td>\n",
       "      <td>February 14, 2018</td>\n",
       "      <td>September 21, 2018</td>\n",
       "      <td>September 21, 2018</td>\n",
       "      <td></td>\n",
       "      <td>Kromerizska nemocniceKromeriz, CzechiaJahn Fer...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03630081</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Study of Cefepime-tazobactam (FEP-TAZ) in Comp...</td>\n",
       "      <td>Complicated Urinary Tract InfectionAcute Pyelo...</td>\n",
       "      <td>Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>WockhardtMedpace Finland OY</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>W-4282-301</td>\n",
       "      <td></td>\n",
       "      <td>July 25, 2019</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>August 14, 2018</td>\n",
       "      <td>February 15, 2019</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03815695</td>\n",
       "      <td>RecruitingNew</td>\n",
       "      <td>A SAD/MAD to Assess the Safety, Pharmacokineti...</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>Drug: FT-4202/PlaceboDrug: FT-4202</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Forma Therapeutics, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Sequ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4202-HVS-101</td>\n",
       "      <td></td>\n",
       "      <td>December 11, 2018</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Medpace Clinical Pharmacology UnitCincinnati, ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03687255</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Safety and Efficacy Study of Cefepime-AAI101 i...</td>\n",
       "      <td>Urinary Tract Infections</td>\n",
       "      <td>Drug: cefepime/AAI101 combinationDrug: Piperac...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>AllecraMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>AT-301</td>\n",
       "      <td></td>\n",
       "      <td>September 24, 2018</td>\n",
       "      <td>November 30, 2019</td>\n",
       "      <td>December 30, 2019</td>\n",
       "      <td>September 27, 2018</td>\n",
       "      <td>September 28, 2018</td>\n",
       "      <td></td>\n",
       "      <td>St. Josephs Clinical ResearchAnaheim, Californ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03680612</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Cefepime/AAI101 Phase 2 Study in Hospitalized ...</td>\n",
       "      <td>Urinary Tract Infections</td>\n",
       "      <td>Drug: Cefepime 1G - 2G / AAI101 0.5G - 0.75GDr...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>AllecraMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>AT-201</td>\n",
       "      <td></td>\n",
       "      <td>September 5, 2017</td>\n",
       "      <td>February 14, 2018</td>\n",
       "      <td>February 14, 2018</td>\n",
       "      <td>September 21, 2018</td>\n",
       "      <td>September 21, 2018</td>\n",
       "      <td></td>\n",
       "      <td>Kromerizska nemocniceKromeriz, CzechiaJahn Fer...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03635996</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Safety Study of Intranasal Etripamil for the T...</td>\n",
       "      <td>Paroxysmal Supraventricular Tachycardia</td>\n",
       "      <td>Drug: Etripamil NS 70 mg</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Milestone Pharmaceuticals Inc.Medpace, Inc.</td>\n",
       "      <td>Other / Industry</td>\n",
       "      <td>Intervention Model: Single Group AssignmentMas...</td>\n",
       "      <td>...</td>\n",
       "      <td>MSP-2017-1158</td>\n",
       "      <td></td>\n",
       "      <td>December 10, 2018</td>\n",
       "      <td>December 2021</td>\n",
       "      <td>December 2021</td>\n",
       "      <td>August 17, 2018</td>\n",
       "      <td>February 11, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Arizona Arrhythmia Research CenterPhoenix, Ari...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03630081</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Study of Cefepime-tazobactam (FEP-TAZ) in Comp...</td>\n",
       "      <td>Complicated Urinary Tract InfectionAcute Pyelo...</td>\n",
       "      <td>Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>WockhardtMedpace Finland OY</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>W-4282-301</td>\n",
       "      <td></td>\n",
       "      <td>July 25, 2019</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>August 14, 2018</td>\n",
       "      <td>February 15, 2019</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03815695</td>\n",
       "      <td>RecruitingNew</td>\n",
       "      <td>A SAD/MAD to Assess the Safety, Pharmacokineti...</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>Drug: FT-4202/PlaceboDrug: FT-4202</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Forma Therapeutics, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Sequ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4202-HVS-101</td>\n",
       "      <td></td>\n",
       "      <td>December 11, 2018</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Medpace Clinical Pharmacology UnitCincinnati, ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03687255</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Safety and Efficacy Study of Cefepime-AAI101 i...</td>\n",
       "      <td>Urinary Tract Infections</td>\n",
       "      <td>Drug: cefepime/AAI101 combinationDrug: Piperac...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>AllecraMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>AT-301</td>\n",
       "      <td></td>\n",
       "      <td>September 24, 2018</td>\n",
       "      <td>November 30, 2019</td>\n",
       "      <td>December 30, 2019</td>\n",
       "      <td>September 27, 2018</td>\n",
       "      <td>September 28, 2018</td>\n",
       "      <td></td>\n",
       "      <td>St. Josephs Clinical ResearchAnaheim, Californ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03680612</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Cefepime/AAI101 Phase 2 Study in Hospitalized ...</td>\n",
       "      <td>Urinary Tract Infections</td>\n",
       "      <td>Drug: Cefepime 1G - 2G / AAI101 0.5G - 0.75GDr...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>AllecraMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>AT-201</td>\n",
       "      <td></td>\n",
       "      <td>September 5, 2017</td>\n",
       "      <td>February 14, 2018</td>\n",
       "      <td>February 14, 2018</td>\n",
       "      <td>September 21, 2018</td>\n",
       "      <td>September 21, 2018</td>\n",
       "      <td></td>\n",
       "      <td>Kromerizska nemocniceKromeriz, CzechiaJahn Fer...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03635996</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Safety Study of Intranasal Etripamil for the T...</td>\n",
       "      <td>Paroxysmal Supraventricular Tachycardia</td>\n",
       "      <td>Drug: Etripamil NS 70 mg</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Milestone Pharmaceuticals Inc.Medpace, Inc.</td>\n",
       "      <td>Other / Industry</td>\n",
       "      <td>Intervention Model: Single Group AssignmentMas...</td>\n",
       "      <td>...</td>\n",
       "      <td>MSP-2017-1158</td>\n",
       "      <td></td>\n",
       "      <td>December 10, 2018</td>\n",
       "      <td>December 2021</td>\n",
       "      <td>December 2021</td>\n",
       "      <td>August 17, 2018</td>\n",
       "      <td>February 11, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Arizona Arrhythmia Research CenterPhoenix, Ari...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03625401</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Efficacy and Safety of AD-35 in Treatment of S...</td>\n",
       "      <td>Alzheimer Disease, Early Onset</td>\n",
       "      <td>Drug: AD-35 60mg groupDrug: AD-35 90mg groupDr...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Zhejiang Hisun Pharmaceutical Co. Ltd.Medpace,...</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>Hisun-AD-35-003</td>\n",
       "      <td>ROAD</td>\n",
       "      <td>October 4, 2018</td>\n",
       "      <td>July 31, 2019</td>\n",
       "      <td>July 31, 2020</td>\n",
       "      <td>August 10, 2018</td>\n",
       "      <td>January 11, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Northern California ResearchSacramento, Califo...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03630081</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Study of Cefepime-tazobactam (FEP-TAZ) in Comp...</td>\n",
       "      <td>Complicated Urinary Tract InfectionAcute Pyelo...</td>\n",
       "      <td>Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>WockhardtMedpace Finland OY</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>W-4282-301</td>\n",
       "      <td></td>\n",
       "      <td>July 25, 2019</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>August 14, 2018</td>\n",
       "      <td>February 15, 2019</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03815695</td>\n",
       "      <td>RecruitingNew</td>\n",
       "      <td>A SAD/MAD to Assess the Safety, Pharmacokineti...</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>Drug: FT-4202/PlaceboDrug: FT-4202</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Forma Therapeutics, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Sequ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4202-HVS-101</td>\n",
       "      <td></td>\n",
       "      <td>December 11, 2018</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Medpace Clinical Pharmacology UnitCincinnati, ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT03687255</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Safety and Efficacy Study of Cefepime-AAI101 i...</td>\n",
       "      <td>Urinary Tract Infections</td>\n",
       "      <td>Drug: cefepime/AAI101 combinationDrug: Piperac...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>AllecraMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>AT-301</td>\n",
       "      <td></td>\n",
       "      <td>September 24, 2018</td>\n",
       "      <td>November 30, 2019</td>\n",
       "      <td>December 30, 2019</td>\n",
       "      <td>September 27, 2018</td>\n",
       "      <td>September 28, 2018</td>\n",
       "      <td></td>\n",
       "      <td>St. Josephs Clinical ResearchAnaheim, Californ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT03680612</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Cefepime/AAI101 Phase 2 Study in Hospitalized ...</td>\n",
       "      <td>Urinary Tract Infections</td>\n",
       "      <td>Drug: Cefepime 1G - 2G / AAI101 0.5G - 0.75GDr...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>AllecraMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>AT-201</td>\n",
       "      <td></td>\n",
       "      <td>September 5, 2017</td>\n",
       "      <td>February 14, 2018</td>\n",
       "      <td>February 14, 2018</td>\n",
       "      <td>September 21, 2018</td>\n",
       "      <td>September 21, 2018</td>\n",
       "      <td></td>\n",
       "      <td>Kromerizska nemocniceKromeriz, CzechiaJahn Fer...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT03635996</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Safety Study of Intranasal Etripamil for the T...</td>\n",
       "      <td>Paroxysmal Supraventricular Tachycardia</td>\n",
       "      <td>Drug: Etripamil NS 70 mg</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Milestone Pharmaceuticals Inc.Medpace, Inc.</td>\n",
       "      <td>Other / Industry</td>\n",
       "      <td>Intervention Model: Single Group AssignmentMas...</td>\n",
       "      <td>...</td>\n",
       "      <td>MSP-2017-1158</td>\n",
       "      <td></td>\n",
       "      <td>December 10, 2018</td>\n",
       "      <td>December 2021</td>\n",
       "      <td>December 2021</td>\n",
       "      <td>August 17, 2018</td>\n",
       "      <td>February 11, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Arizona Arrhythmia Research CenterPhoenix, Ari...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NCT03625401</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Efficacy and Safety of AD-35 in Treatment of S...</td>\n",
       "      <td>Alzheimer Disease, Early Onset</td>\n",
       "      <td>Drug: AD-35 60mg groupDrug: AD-35 90mg groupDr...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Zhejiang Hisun Pharmaceutical Co. Ltd.Medpace,...</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>Hisun-AD-35-003</td>\n",
       "      <td>ROAD</td>\n",
       "      <td>October 4, 2018</td>\n",
       "      <td>July 31, 2019</td>\n",
       "      <td>July 31, 2020</td>\n",
       "      <td>August 10, 2018</td>\n",
       "      <td>January 11, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Northern California ResearchSacramento, Califo...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NCT03574363</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>Phase 2b Study of KBP-5074 in Subjects With Un...</td>\n",
       "      <td>Chronic Kidney DiseasesHypertension</td>\n",
       "      <td>Drug: KBP-5074</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>KBP BiosciencesMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>KBP5074-2-001</td>\n",
       "      <td>BLOCKCKD</td>\n",
       "      <td>April 25, 2018</td>\n",
       "      <td>October 31, 2019</td>\n",
       "      <td>December 12, 2019</td>\n",
       "      <td>July 2, 2018</td>\n",
       "      <td>July 2, 2018</td>\n",
       "      <td></td>\n",
       "      <td>MedpaceCincinnati, Ohio, United States</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT03630081</td>\n",
       "      <td>Not yet recruiting</td>\n",
       "      <td>Study of Cefepime-tazobactam (FEP-TAZ) in Comp...</td>\n",
       "      <td>Complicated Urinary Tract InfectionAcute Pyelo...</td>\n",
       "      <td>Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>WockhardtMedpace Finland OY</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>W-4282-301</td>\n",
       "      <td></td>\n",
       "      <td>July 25, 2019</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>December 25, 2020</td>\n",
       "      <td>August 14, 2018</td>\n",
       "      <td>February 15, 2019</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT03815695</td>\n",
       "      <td>RecruitingNew</td>\n",
       "      <td>A SAD/MAD to Assess the Safety, Pharmacokineti...</td>\n",
       "      <td>Healthy Volunteers</td>\n",
       "      <td>Drug: FT-4202/PlaceboDrug: FT-4202</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Forma Therapeutics, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Sequ...</td>\n",
       "      <td>...</td>\n",
       "      <td>4202-HVS-101</td>\n",
       "      <td></td>\n",
       "      <td>December 11, 2018</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>December 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td>January 24, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Medpace Clinical Pharmacology UnitCincinnati, ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>NCT01699061</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Effect of Tivantinib on the QTC Interval in Ca...</td>\n",
       "      <td>Solid Tumors</td>\n",
       "      <td>Drug: TivantinibDrug: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Daiichi Sankyo, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: Non-RandomizedIntervention Model: ...</td>\n",
       "      <td>...</td>\n",
       "      <td>ARQ197-A-U159</td>\n",
       "      <td></td>\n",
       "      <td>July 2012</td>\n",
       "      <td>January 2013</td>\n",
       "      <td>May 2013</td>\n",
       "      <td>October 3, 2012</td>\n",
       "      <td>February 12, 2019</td>\n",
       "      <td></td>\n",
       "      <td>START - South Texas Accelerated Research Thera...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>NCT01658826</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Safety and Efficacy Comparator Trial of a New ...</td>\n",
       "      <td>Genital Herpes</td>\n",
       "      <td>Drug: AIC316Drug: Valacyclovir</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>AiCuris Anti-infective Cures GmbHMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Cros...</td>\n",
       "      <td>...</td>\n",
       "      <td>AIC316-01-II-02</td>\n",
       "      <td></td>\n",
       "      <td>October 2012</td>\n",
       "      <td>May 2013</td>\n",
       "      <td>July 2013</td>\n",
       "      <td>August 7, 2012</td>\n",
       "      <td>September 23, 2016</td>\n",
       "      <td></td>\n",
       "      <td>Indiana University School of Medicine, IU Infe...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>NCT01517399</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Drug-drug Interaction Study of Tivantinib (ARQ...</td>\n",
       "      <td>Solid Tumors</td>\n",
       "      <td>Drug: tivantinibDrug: omeprazoleDrug: s-warfar...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Daiichi Sankyo, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Intervention Model: Sequential AssignmentMaski...</td>\n",
       "      <td>...</td>\n",
       "      <td>ARQ197-A-U158</td>\n",
       "      <td></td>\n",
       "      <td>December 2011</td>\n",
       "      <td>August 2013</td>\n",
       "      <td>September 2013</td>\n",
       "      <td>January 25, 2012</td>\n",
       "      <td>February 12, 2019</td>\n",
       "      <td></td>\n",
       "      <td>START - South Texas Accelerated Research Thera...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>NCT01436487</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Study to Examine the Effects of MultiStem in I...</td>\n",
       "      <td>Ischemic Stroke</td>\n",
       "      <td>Biological: MultiStemBiological: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Athersys, IncMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>B01-02</td>\n",
       "      <td></td>\n",
       "      <td>October 2011</td>\n",
       "      <td>March 2015</td>\n",
       "      <td>December 2015</td>\n",
       "      <td>September 19, 2011</td>\n",
       "      <td>August 2, 2016</td>\n",
       "      <td></td>\n",
       "      <td>UCLA Medical CenterLos Angeles, California, Un...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>NCT01428362</td>\n",
       "      <td>Completed</td>\n",
       "      <td>VI-1121 for the Treatment Alzheimer's Disease</td>\n",
       "      <td>Alzheimer's Disease</td>\n",
       "      <td>Drug: VI-1121Drug: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>VIVUS, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Cros...</td>\n",
       "      <td>...</td>\n",
       "      <td>AD-201</td>\n",
       "      <td>AD-201</td>\n",
       "      <td>August 2011</td>\n",
       "      <td>August 2013</td>\n",
       "      <td>August 2013</td>\n",
       "      <td>September 5, 2011</td>\n",
       "      <td>December 11, 2013</td>\n",
       "      <td></td>\n",
       "      <td>San Francisco, California, United StatesSanta ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>NCT01211847</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Efficacy Study of Diazoxide Choline to Treat H...</td>\n",
       "      <td>HypertriglyceridemiaDyslipidemia</td>\n",
       "      <td>Drug: Diazoxide Choline Controlled-Release Tab...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Essentialis, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>CT013</td>\n",
       "      <td></td>\n",
       "      <td>October 2010</td>\n",
       "      <td>September 2011</td>\n",
       "      <td>December 2011</td>\n",
       "      <td>September 30, 2010</td>\n",
       "      <td>January 10, 2014</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>NCT01139814</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>Clinical Study to Evaluate the Catheter Roboti...</td>\n",
       "      <td>Atrial FlutterVentricular Tachycardia</td>\n",
       "      <td>Device: Amigo catheter robot</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>Catheter Robotics, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Intervention Model: Single Group AssignmentMas...</td>\n",
       "      <td>...</td>\n",
       "      <td>2008-001-01</td>\n",
       "      <td></td>\n",
       "      <td>June 2010</td>\n",
       "      <td>October 2011</td>\n",
       "      <td>October 2011</td>\n",
       "      <td>June 9, 2010</td>\n",
       "      <td>April 11, 2013</td>\n",
       "      <td>April 10, 2013</td>\n",
       "      <td>Hoag Memorial Hospital PresbyterianNewport Bea...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>NCT00868439</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>Evaluation of Patiromer in Heart Failure Patients</td>\n",
       "      <td>HyperkalemiaHeart Failure</td>\n",
       "      <td>Drug: patiromerDrug: placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Relypsa, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>RLY5016-202</td>\n",
       "      <td>PEARL-HF</td>\n",
       "      <td>April 2009</td>\n",
       "      <td>November 2009</td>\n",
       "      <td>December 2009</td>\n",
       "      <td>March 25, 2009</td>\n",
       "      <td>February 25, 2016</td>\n",
       "      <td>December 15, 2015</td>\n",
       "      <td>Investigator Site 029Miami, Florida, United St...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>NCT00796367</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>A Safety and Efficacy Study of VI-0521 to Eval...</td>\n",
       "      <td>Obesity</td>\n",
       "      <td>Drug: VI-0521Drug: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>VIVUS, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>OB-305</td>\n",
       "      <td></td>\n",
       "      <td>December 2008</td>\n",
       "      <td>June 2010</td>\n",
       "      <td>July 2010</td>\n",
       "      <td>November 24, 2008</td>\n",
       "      <td>September 10, 2012</td>\n",
       "      <td>August 31, 2012</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>NCT00696475</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Diazoxide Choline in Hypertriglyceridemia</td>\n",
       "      <td>Hypertriglyceridemia</td>\n",
       "      <td>Drug: Diazoxide cholineDrug: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Essentialis, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>PC007</td>\n",
       "      <td></td>\n",
       "      <td>June 2008</td>\n",
       "      <td>January 2009</td>\n",
       "      <td>March 2009</td>\n",
       "      <td>June 12, 2008</td>\n",
       "      <td>November 8, 2010</td>\n",
       "      <td></td>\n",
       "      <td>National Research InstituteLos Angeles, Califo...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>NCT00563368</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>A Study Comparing Multiple Doses of VI-0521 Wi...</td>\n",
       "      <td>Obesity</td>\n",
       "      <td>Drug: VI-0521Drug: topiramateDrug: phentermine</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>VIVUS, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>OB-301</td>\n",
       "      <td></td>\n",
       "      <td>December 2007</td>\n",
       "      <td>September 2008</td>\n",
       "      <td>September 2008</td>\n",
       "      <td>November 26, 2007</td>\n",
       "      <td>March 30, 2015</td>\n",
       "      <td>September 3, 2012</td>\n",
       "      <td>Research SiteDurham, North Carolina, United St...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>NCT00554216</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>Study of VI-0521 Compared to Placebo in Treatm...</td>\n",
       "      <td>Obesity</td>\n",
       "      <td>Drug: VI-0521Drug: Placebo matched phentermine...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>VIVUS, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>OB-302</td>\n",
       "      <td></td>\n",
       "      <td>November 2007</td>\n",
       "      <td>May 2009</td>\n",
       "      <td>May 2009</td>\n",
       "      <td>November 6, 2007</td>\n",
       "      <td>September 10, 2012</td>\n",
       "      <td>September 6, 2012</td>\n",
       "      <td>Research SiteSan Diego, California, United Sta...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>NCT00553787</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>Study of VI-0521 Compared to Placebo in Treatm...</td>\n",
       "      <td>ObesityType 2 Diabetes</td>\n",
       "      <td>Drug: VI-0521</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>VIVUS, Inc.Medpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>OB-303</td>\n",
       "      <td></td>\n",
       "      <td>November 2007</td>\n",
       "      <td>June 2009</td>\n",
       "      <td>June 2009</td>\n",
       "      <td>November 6, 2007</td>\n",
       "      <td>September 10, 2012</td>\n",
       "      <td>September 6, 2012</td>\n",
       "      <td>Research SiteBirmingham, Alabama, United State...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>NCT03008187</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>SEL24/MEN1703 in Patients With Acute Myeloid L...</td>\n",
       "      <td>Acute Myeloid Leukemia</td>\n",
       "      <td>Drug: SEL24/MEN1703</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1Phase 2</td>\n",
       "      <td>Menarini GroupMedpace, Inc.Theradex</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Intervention Model: Single Group AssignmentMas...</td>\n",
       "      <td>...</td>\n",
       "      <td>CLI24-001</td>\n",
       "      <td></td>\n",
       "      <td>January 2017</td>\n",
       "      <td>February 2019</td>\n",
       "      <td>May 2020</td>\n",
       "      <td>January 2, 2017</td>\n",
       "      <td>December 12, 2018</td>\n",
       "      <td></td>\n",
       "      <td>Northside HospitalAtlanta, Georgia, United Sta...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>NCT02946073</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Buprenorphine (CAM2038) in Subjects With a Rec...</td>\n",
       "      <td>Chronic Lower Back PainChronic Pain</td>\n",
       "      <td>Drug: buprenorphineOther: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Braeburn PharmaceuticalsMedpace, Inc.Camurus AB</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>HS-16-555</td>\n",
       "      <td>CAM2038</td>\n",
       "      <td>September 2016</td>\n",
       "      <td>May 2018</td>\n",
       "      <td>January 2019</td>\n",
       "      <td>October 26, 2016</td>\n",
       "      <td>July 18, 2018</td>\n",
       "      <td></td>\n",
       "      <td>Parkway Medical CenterBirmingham, Alabama, Uni...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>NCT02865915</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>MLE4901 vs. Placebo for the Treatment of PCOS</td>\n",
       "      <td>Polycystic Ovary Syndrome (PCOS)</td>\n",
       "      <td>Drug: MLE4901 40mgDrug: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Millendo Therapeutics, Inc.Medpace, Inc.Covance</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>MLE4901-1012016-002179-91</td>\n",
       "      <td></td>\n",
       "      <td>July 2016</td>\n",
       "      <td>September 2017</td>\n",
       "      <td>September 2017</td>\n",
       "      <td>August 15, 2016</td>\n",
       "      <td>October 2, 2017</td>\n",
       "      <td></td>\n",
       "      <td>Hope Research Institute, LLCPhoenix, Arizona, ...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>NCT02156843</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Pyridorin in Diabetic Nephropathy</td>\n",
       "      <td>Diabetic NephropathyDiabetic Kidney Disease</td>\n",
       "      <td>Drug: PyridorinDrug: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>NephroGenex, Inc.Collaborative Study Group (CS...</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>PYR-3112014-001641-24CSG-17PYR-311 (PIONEER)</td>\n",
       "      <td>PIONEER</td>\n",
       "      <td>June 2014</td>\n",
       "      <td>December 2017</td>\n",
       "      <td>March 2018</td>\n",
       "      <td>June 5, 2014</td>\n",
       "      <td>March 9, 2016</td>\n",
       "      <td></td>\n",
       "      <td>CSG Investigational Site (#157)Birmingham, Ala...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>NCT01004770</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>Single Dose Safety, Tolerance and Pharmacokine...</td>\n",
       "      <td>Healthy</td>\n",
       "      <td>Drug: GE-145 (AN113111) InjectionDrug: Visipaq...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1Phase 2</td>\n",
       "      <td>GE HealthcareMedpace, Inc.i3 Statprobe</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: Non-RandomizedIntervention Model: ...</td>\n",
       "      <td>...</td>\n",
       "      <td>GE-145-001</td>\n",
       "      <td></td>\n",
       "      <td>October 2009</td>\n",
       "      <td>February 2010</td>\n",
       "      <td>May 2010</td>\n",
       "      <td>October 30, 2009</td>\n",
       "      <td>April 5, 2012</td>\n",
       "      <td>April 4, 2012</td>\n",
       "      <td>GE HealthcarePrinceton, New Jersey, United States</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>NCT01919684</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Study to Evaluate Safety, Tolerability, Pharma...</td>\n",
       "      <td>Type 2 Diabetes Mellitus</td>\n",
       "      <td>Drug: LGD-6972Drug: Placebo (Captisol®)</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>Ligand PharmaceuticalsBeckloff Associates, Inc...</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>L6972-01</td>\n",
       "      <td></td>\n",
       "      <td>November 2013</td>\n",
       "      <td>February 2014</td>\n",
       "      <td>March 2014</td>\n",
       "      <td>August 9, 2013</td>\n",
       "      <td>September 25, 2014</td>\n",
       "      <td></td>\n",
       "      <td>Medpace Clinical PharmacologyCincinnati, Ohio,...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>NCT01489566</td>\n",
       "      <td>Unknown †</td>\n",
       "      <td>Study of Tyroserleutide for Injection in Hepat...</td>\n",
       "      <td>Hepatocellular,Carcinoma</td>\n",
       "      <td>Drug: Tyroserleutide for injection ,chemothera...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Shenzhen Kangzhe Pharmaceutical Co., Ltd.Fudan...</td>\n",
       "      <td>Other / Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>TYS-CN-1.1PUMP III</td>\n",
       "      <td></td>\n",
       "      <td>July 2011</td>\n",
       "      <td>March 2013</td>\n",
       "      <td>August 2013</td>\n",
       "      <td>December 9, 2011</td>\n",
       "      <td>December 14, 2011</td>\n",
       "      <td></td>\n",
       "      <td>Fudan University Zhongshan HospitalShanghai, S...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>NCT01408303</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>[E]PANOVA Combined With a [S]TATIN in [P]ATIEN...</td>\n",
       "      <td>HypertriglyceridemiaCardiovascular Disease</td>\n",
       "      <td>Drug: Olive oil, 4gDrug: omega-3-carboxylic ac...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>AstraZenecaOmthera Pharmaceuticals, IncMedpace...</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>OM-EPA-004</td>\n",
       "      <td>ESPRIT</td>\n",
       "      <td>August 2011</td>\n",
       "      <td>June 2012</td>\n",
       "      <td>June 2012</td>\n",
       "      <td>August 3, 2011</td>\n",
       "      <td>December 5, 2014</td>\n",
       "      <td>December 5, 2014</td>\n",
       "      <td>Muscle Shoals, Alabama, United StatesChandler,...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>NCT01265394</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>Positron Emission Tomography (PET) Amyloid Ima...</td>\n",
       "      <td>Healthy</td>\n",
       "      <td>Drug: [18F] Flutemetamol</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>GE Healthcarei3 StatprobeMedpace, Inc.</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: Non-RandomizedIntervention Model: ...</td>\n",
       "      <td>...</td>\n",
       "      <td>GE-067-015</td>\n",
       "      <td></td>\n",
       "      <td>December 2010</td>\n",
       "      <td>March 2011</td>\n",
       "      <td>April 2011</td>\n",
       "      <td>December 23, 2010</td>\n",
       "      <td>July 2, 2013</td>\n",
       "      <td>June 21, 2013</td>\n",
       "      <td>GE HealthcarePrinceton, New Jersey, United States</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>NCT00734253</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Safety and Efficacy Study of Pyridorin in Pati...</td>\n",
       "      <td>Diabetic Nephropathy</td>\n",
       "      <td>Drug: Pyridoxamine DihydrochlorideDrug: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>NephroGenex, Inc.Collaborative Study Group (CS...</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>PYR-210</td>\n",
       "      <td></td>\n",
       "      <td>August 2008</td>\n",
       "      <td>August 2010</td>\n",
       "      <td>August 2010</td>\n",
       "      <td>August 14, 2008</td>\n",
       "      <td>October 28, 2015</td>\n",
       "      <td></td>\n",
       "      <td>The Collaborative Study GroupChicago, Illinois...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>NCT02525939</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Effect of Dalcetrapib vs Placebo on CV Risk in...</td>\n",
       "      <td>Acute Coronary Syndrome</td>\n",
       "      <td>Drug: dalcetrapibDrug: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>DalCor PharmaceuticalsThe Montreal Health Inno...</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>DAL-301</td>\n",
       "      <td>dal-GenE</td>\n",
       "      <td>April 2016</td>\n",
       "      <td>August 2020</td>\n",
       "      <td>August 2020</td>\n",
       "      <td>August 18, 2015</td>\n",
       "      <td>December 19, 2018</td>\n",
       "      <td></td>\n",
       "      <td>Research SiteAlexander City, Alabama, United S...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>NCT00785759</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Brain Uptake and Safety With Probable Alzheime...</td>\n",
       "      <td>Alzheimer's DiseaseAmnestic Mild Cognitive Imp...</td>\n",
       "      <td>Drug: AH110690 (18F) Injection</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>GE Healthcarei3 StatprobeMedpace, Inc.Hvidovre...</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Intervention Model: Single Group AssignmentMas...</td>\n",
       "      <td>...</td>\n",
       "      <td>ALZ201</td>\n",
       "      <td>ALZ201</td>\n",
       "      <td>September 2008</td>\n",
       "      <td>March 2009</td>\n",
       "      <td>December 2009</td>\n",
       "      <td>November 5, 2008</td>\n",
       "      <td>December 7, 2009</td>\n",
       "      <td></td>\n",
       "      <td>GE HealthcareOslo, Norway</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>NCT01028053</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>Assess the Prognostic Usefulness of Flutemetam...</td>\n",
       "      <td>Mild Cognitive ImpairmentAlzheimer's Disease</td>\n",
       "      <td>Drug: Flutemetamol (18F) Injection</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>GE HealthcareMedpace, Inc.i3 Statprobe(and 2 m...</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Intervention Model: Single Group AssignmentMas...</td>\n",
       "      <td>...</td>\n",
       "      <td>GE-067-005</td>\n",
       "      <td></td>\n",
       "      <td>December 2009</td>\n",
       "      <td>January 2014</td>\n",
       "      <td>January 2014</td>\n",
       "      <td>December 9, 2009</td>\n",
       "      <td>September 11, 2014</td>\n",
       "      <td>September 11, 2014</td>\n",
       "      <td>GE HealthcarePrinceton, New Jersey, United States</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>NCT01252810</td>\n",
       "      <td>CompletedHas Results</td>\n",
       "      <td>Safety Study of GE-145 320 mg I/mL Injection v...</td>\n",
       "      <td>Chronic Renal InsufficiencyDiabete MellitusCon...</td>\n",
       "      <td>Drug: GE-145</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>GE Healthcarei3 StatprobeMedpace, Inc.(and 2 m...</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>GE 145-002</td>\n",
       "      <td></td>\n",
       "      <td>November 2010</td>\n",
       "      <td>December 2012</td>\n",
       "      <td>December 2012</td>\n",
       "      <td>December 3, 2010</td>\n",
       "      <td>August 29, 2018</td>\n",
       "      <td>May 2, 2014</td>\n",
       "      <td>GE HealthcarePrinceton, New Jersey, United States</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>NCT02436876</td>\n",
       "      <td>Active, not recruiting</td>\n",
       "      <td>Study to Assess Safety and Clinical Activity o...</td>\n",
       "      <td>Bacterial Infection</td>\n",
       "      <td>Drug: MBN-101Other: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Microbion CorporationUniversity of Pennsylvani...</td>\n",
       "      <td>Industry / Other / U.S. Fed</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>MBN-101-201W81XWH-12-2-0100</td>\n",
       "      <td></td>\n",
       "      <td>January 2016</td>\n",
       "      <td>September 1, 2018</td>\n",
       "      <td>December 31, 2018</td>\n",
       "      <td>May 7, 2015</td>\n",
       "      <td>August 13, 2018</td>\n",
       "      <td></td>\n",
       "      <td>Orthopedic Trauma Institute, University of Cal...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>NCT03449524</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>PRIMEx - A Study of 2 Doses of Oral CXA-10 in ...</td>\n",
       "      <td>PAH</td>\n",
       "      <td>Drug: 75mg CXA-10Drug: 150mg CXA-10Other: Placebo</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Complexa, Inc.Clinical WorksMedpace, Inc.(and ...</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>CXA-10-301</td>\n",
       "      <td>PAH</td>\n",
       "      <td>August 1, 2018</td>\n",
       "      <td>August 2019</td>\n",
       "      <td>August 2019</td>\n",
       "      <td>February 28, 2018</td>\n",
       "      <td>January 11, 2019</td>\n",
       "      <td></td>\n",
       "      <td>University of AlabamaBirmingham, Alabama, Unit...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>NCT03422510</td>\n",
       "      <td>Recruiting</td>\n",
       "      <td>FIRSTx - A Study of Oral CXA-10 in Primary Foc...</td>\n",
       "      <td>Primary Focal Segmental Glomerulosclerosis</td>\n",
       "      <td>Drug: CXA-10</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>Complexa, Inc.Kidney Research Network, formerl...</td>\n",
       "      <td>Industry / Other</td>\n",
       "      <td>Allocation: RandomizedIntervention Model: Para...</td>\n",
       "      <td>...</td>\n",
       "      <td>CXA-10-204</td>\n",
       "      <td></td>\n",
       "      <td>April 15, 2018</td>\n",
       "      <td>July 2019</td>\n",
       "      <td>July 2019</td>\n",
       "      <td>February 5, 2018</td>\n",
       "      <td>January 15, 2019</td>\n",
       "      <td></td>\n",
       "      <td>Cedars Sinai Medical CenterLos Angeles, Califo...</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1891 rows × 25 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "     NCT Number                  Status  \\\n",
       "0   NCT03630081      Not yet recruiting   \n",
       "0   NCT03630081      Not yet recruiting   \n",
       "1   NCT03815695           RecruitingNew   \n",
       "0   NCT03630081      Not yet recruiting   \n",
       "1   NCT03815695           RecruitingNew   \n",
       "2   NCT03687255              Recruiting   \n",
       "0   NCT03630081      Not yet recruiting   \n",
       "1   NCT03815695           RecruitingNew   \n",
       "2   NCT03687255              Recruiting   \n",
       "3   NCT03680612               Completed   \n",
       "0   NCT03630081      Not yet recruiting   \n",
       "1   NCT03815695           RecruitingNew   \n",
       "2   NCT03687255              Recruiting   \n",
       "3   NCT03680612               Completed   \n",
       "4   NCT03635996              Recruiting   \n",
       "0   NCT03630081      Not yet recruiting   \n",
       "1   NCT03815695           RecruitingNew   \n",
       "2   NCT03687255              Recruiting   \n",
       "3   NCT03680612               Completed   \n",
       "4   NCT03635996              Recruiting   \n",
       "5   NCT03625401              Recruiting   \n",
       "0   NCT03630081      Not yet recruiting   \n",
       "1   NCT03815695           RecruitingNew   \n",
       "2   NCT03687255              Recruiting   \n",
       "3   NCT03680612               Completed   \n",
       "4   NCT03635996              Recruiting   \n",
       "5   NCT03625401              Recruiting   \n",
       "6   NCT03574363              Recruiting   \n",
       "0   NCT03630081      Not yet recruiting   \n",
       "1   NCT03815695           RecruitingNew   \n",
       "..          ...                     ...   \n",
       "31  NCT01699061               Completed   \n",
       "32  NCT01658826              Terminated   \n",
       "33  NCT01517399               Completed   \n",
       "34  NCT01436487               Completed   \n",
       "35  NCT01428362               Completed   \n",
       "36  NCT01211847               Completed   \n",
       "37  NCT01139814    CompletedHas Results   \n",
       "38  NCT00868439    CompletedHas Results   \n",
       "39  NCT00796367    CompletedHas Results   \n",
       "40  NCT00696475               Completed   \n",
       "41  NCT00563368    CompletedHas Results   \n",
       "42  NCT00554216    CompletedHas Results   \n",
       "43  NCT00553787    CompletedHas Results   \n",
       "44  NCT03008187              Recruiting   \n",
       "45  NCT02946073  Active, not recruiting   \n",
       "46  NCT02865915              Terminated   \n",
       "47  NCT02156843              Terminated   \n",
       "48  NCT01004770    CompletedHas Results   \n",
       "49  NCT01919684               Completed   \n",
       "50  NCT01489566               Unknown †   \n",
       "51  NCT01408303    CompletedHas Results   \n",
       "52  NCT01265394    CompletedHas Results   \n",
       "53  NCT00734253               Completed   \n",
       "54  NCT02525939  Active, not recruiting   \n",
       "55  NCT00785759               Completed   \n",
       "56  NCT01028053    CompletedHas Results   \n",
       "57  NCT01252810    CompletedHas Results   \n",
       "58  NCT02436876  Active, not recruiting   \n",
       "59  NCT03449524              Recruiting   \n",
       "60  NCT03422510              Recruiting   \n",
       "\n",
       "                                                Title  \\\n",
       "0   Study of Cefepime-tazobactam (FEP-TAZ) in Comp...   \n",
       "0   Study of Cefepime-tazobactam (FEP-TAZ) in Comp...   \n",
       "1   A SAD/MAD to Assess the Safety, Pharmacokineti...   \n",
       "0   Study of Cefepime-tazobactam (FEP-TAZ) in Comp...   \n",
       "1   A SAD/MAD to Assess the Safety, Pharmacokineti...   \n",
       "2   Safety and Efficacy Study of Cefepime-AAI101 i...   \n",
       "0   Study of Cefepime-tazobactam (FEP-TAZ) in Comp...   \n",
       "1   A SAD/MAD to Assess the Safety, Pharmacokineti...   \n",
       "2   Safety and Efficacy Study of Cefepime-AAI101 i...   \n",
       "3   Cefepime/AAI101 Phase 2 Study in Hospitalized ...   \n",
       "0   Study of Cefepime-tazobactam (FEP-TAZ) in Comp...   \n",
       "1   A SAD/MAD to Assess the Safety, Pharmacokineti...   \n",
       "2   Safety and Efficacy Study of Cefepime-AAI101 i...   \n",
       "3   Cefepime/AAI101 Phase 2 Study in Hospitalized ...   \n",
       "4   Safety Study of Intranasal Etripamil for the T...   \n",
       "0   Study of Cefepime-tazobactam (FEP-TAZ) in Comp...   \n",
       "1   A SAD/MAD to Assess the Safety, Pharmacokineti...   \n",
       "2   Safety and Efficacy Study of Cefepime-AAI101 i...   \n",
       "3   Cefepime/AAI101 Phase 2 Study in Hospitalized ...   \n",
       "4   Safety Study of Intranasal Etripamil for the T...   \n",
       "5   Efficacy and Safety of AD-35 in Treatment of S...   \n",
       "0   Study of Cefepime-tazobactam (FEP-TAZ) in Comp...   \n",
       "1   A SAD/MAD to Assess the Safety, Pharmacokineti...   \n",
       "2   Safety and Efficacy Study of Cefepime-AAI101 i...   \n",
       "3   Cefepime/AAI101 Phase 2 Study in Hospitalized ...   \n",
       "4   Safety Study of Intranasal Etripamil for the T...   \n",
       "5   Efficacy and Safety of AD-35 in Treatment of S...   \n",
       "6   Phase 2b Study of KBP-5074 in Subjects With Un...   \n",
       "0   Study of Cefepime-tazobactam (FEP-TAZ) in Comp...   \n",
       "1   A SAD/MAD to Assess the Safety, Pharmacokineti...   \n",
       "..                                                ...   \n",
       "31  Effect of Tivantinib on the QTC Interval in Ca...   \n",
       "32  Safety and Efficacy Comparator Trial of a New ...   \n",
       "33  Drug-drug Interaction Study of Tivantinib (ARQ...   \n",
       "34  Study to Examine the Effects of MultiStem in I...   \n",
       "35      VI-1121 for the Treatment Alzheimer's Disease   \n",
       "36  Efficacy Study of Diazoxide Choline to Treat H...   \n",
       "37  Clinical Study to Evaluate the Catheter Roboti...   \n",
       "38  Evaluation of Patiromer in Heart Failure Patients   \n",
       "39  A Safety and Efficacy Study of VI-0521 to Eval...   \n",
       "40          Diazoxide Choline in Hypertriglyceridemia   \n",
       "41  A Study Comparing Multiple Doses of VI-0521 Wi...   \n",
       "42  Study of VI-0521 Compared to Placebo in Treatm...   \n",
       "43  Study of VI-0521 Compared to Placebo in Treatm...   \n",
       "44  SEL24/MEN1703 in Patients With Acute Myeloid L...   \n",
       "45  Buprenorphine (CAM2038) in Subjects With a Rec...   \n",
       "46      MLE4901 vs. Placebo for the Treatment of PCOS   \n",
       "47                  Pyridorin in Diabetic Nephropathy   \n",
       "48  Single Dose Safety, Tolerance and Pharmacokine...   \n",
       "49  Study to Evaluate Safety, Tolerability, Pharma...   \n",
       "50  Study of Tyroserleutide for Injection in Hepat...   \n",
       "51  [E]PANOVA Combined With a [S]TATIN in [P]ATIEN...   \n",
       "52  Positron Emission Tomography (PET) Amyloid Ima...   \n",
       "53  Safety and Efficacy Study of Pyridorin in Pati...   \n",
       "54  Effect of Dalcetrapib vs Placebo on CV Risk in...   \n",
       "55  Brain Uptake and Safety With Probable Alzheime...   \n",
       "56  Assess the Prognostic Usefulness of Flutemetam...   \n",
       "57  Safety Study of GE-145 320 mg I/mL Injection v...   \n",
       "58  Study to Assess Safety and Clinical Activity o...   \n",
       "59  PRIMEx - A Study of 2 Doses of Oral CXA-10 in ...   \n",
       "60  FIRSTx - A Study of Oral CXA-10 in Primary Foc...   \n",
       "\n",
       "                                           Conditions  \\\n",
       "0   Complicated Urinary Tract InfectionAcute Pyelo...   \n",
       "0   Complicated Urinary Tract InfectionAcute Pyelo...   \n",
       "1                                  Healthy Volunteers   \n",
       "0   Complicated Urinary Tract InfectionAcute Pyelo...   \n",
       "1                                  Healthy Volunteers   \n",
       "2                            Urinary Tract Infections   \n",
       "0   Complicated Urinary Tract InfectionAcute Pyelo...   \n",
       "1                                  Healthy Volunteers   \n",
       "2                            Urinary Tract Infections   \n",
       "3                            Urinary Tract Infections   \n",
       "0   Complicated Urinary Tract InfectionAcute Pyelo...   \n",
       "1                                  Healthy Volunteers   \n",
       "2                            Urinary Tract Infections   \n",
       "3                            Urinary Tract Infections   \n",
       "4             Paroxysmal Supraventricular Tachycardia   \n",
       "0   Complicated Urinary Tract InfectionAcute Pyelo...   \n",
       "1                                  Healthy Volunteers   \n",
       "2                            Urinary Tract Infections   \n",
       "3                            Urinary Tract Infections   \n",
       "4             Paroxysmal Supraventricular Tachycardia   \n",
       "5                      Alzheimer Disease, Early Onset   \n",
       "0   Complicated Urinary Tract InfectionAcute Pyelo...   \n",
       "1                                  Healthy Volunteers   \n",
       "2                            Urinary Tract Infections   \n",
       "3                            Urinary Tract Infections   \n",
       "4             Paroxysmal Supraventricular Tachycardia   \n",
       "5                      Alzheimer Disease, Early Onset   \n",
       "6                 Chronic Kidney DiseasesHypertension   \n",
       "0   Complicated Urinary Tract InfectionAcute Pyelo...   \n",
       "1                                  Healthy Volunteers   \n",
       "..                                                ...   \n",
       "31                                       Solid Tumors   \n",
       "32                                     Genital Herpes   \n",
       "33                                       Solid Tumors   \n",
       "34                                    Ischemic Stroke   \n",
       "35                                Alzheimer's Disease   \n",
       "36                   HypertriglyceridemiaDyslipidemia   \n",
       "37              Atrial FlutterVentricular Tachycardia   \n",
       "38                          HyperkalemiaHeart Failure   \n",
       "39                                            Obesity   \n",
       "40                               Hypertriglyceridemia   \n",
       "41                                            Obesity   \n",
       "42                                            Obesity   \n",
       "43                             ObesityType 2 Diabetes   \n",
       "44                             Acute Myeloid Leukemia   \n",
       "45                Chronic Lower Back PainChronic Pain   \n",
       "46                   Polycystic Ovary Syndrome (PCOS)   \n",
       "47        Diabetic NephropathyDiabetic Kidney Disease   \n",
       "48                                            Healthy   \n",
       "49                           Type 2 Diabetes Mellitus   \n",
       "50                           Hepatocellular,Carcinoma   \n",
       "51         HypertriglyceridemiaCardiovascular Disease   \n",
       "52                                            Healthy   \n",
       "53                               Diabetic Nephropathy   \n",
       "54                            Acute Coronary Syndrome   \n",
       "55  Alzheimer's DiseaseAmnestic Mild Cognitive Imp...   \n",
       "56       Mild Cognitive ImpairmentAlzheimer's Disease   \n",
       "57  Chronic Renal InsufficiencyDiabete MellitusCon...   \n",
       "58                                Bacterial Infection   \n",
       "59                                                PAH   \n",
       "60         Primary Focal Segmental Glomerulosclerosis   \n",
       "\n",
       "                                        Interventions      Study Type  \\\n",
       "0   Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...  Interventional   \n",
       "0   Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...  Interventional   \n",
       "1                  Drug: FT-4202/PlaceboDrug: FT-4202  Interventional   \n",
       "0   Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...  Interventional   \n",
       "1                  Drug: FT-4202/PlaceboDrug: FT-4202  Interventional   \n",
       "2   Drug: cefepime/AAI101 combinationDrug: Piperac...  Interventional   \n",
       "0   Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...  Interventional   \n",
       "1                  Drug: FT-4202/PlaceboDrug: FT-4202  Interventional   \n",
       "2   Drug: cefepime/AAI101 combinationDrug: Piperac...  Interventional   \n",
       "3   Drug: Cefepime 1G - 2G / AAI101 0.5G - 0.75GDr...  Interventional   \n",
       "0   Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...  Interventional   \n",
       "1                  Drug: FT-4202/PlaceboDrug: FT-4202  Interventional   \n",
       "2   Drug: cefepime/AAI101 combinationDrug: Piperac...  Interventional   \n",
       "3   Drug: Cefepime 1G - 2G / AAI101 0.5G - 0.75GDr...  Interventional   \n",
       "4                            Drug: Etripamil NS 70 mg  Interventional   \n",
       "0   Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...  Interventional   \n",
       "1                  Drug: FT-4202/PlaceboDrug: FT-4202  Interventional   \n",
       "2   Drug: cefepime/AAI101 combinationDrug: Piperac...  Interventional   \n",
       "3   Drug: Cefepime 1G - 2G / AAI101 0.5G - 0.75GDr...  Interventional   \n",
       "4                            Drug: Etripamil NS 70 mg  Interventional   \n",
       "5   Drug: AD-35 60mg groupDrug: AD-35 90mg groupDr...  Interventional   \n",
       "0   Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...  Interventional   \n",
       "1                  Drug: FT-4202/PlaceboDrug: FT-4202  Interventional   \n",
       "2   Drug: cefepime/AAI101 combinationDrug: Piperac...  Interventional   \n",
       "3   Drug: Cefepime 1G - 2G / AAI101 0.5G - 0.75GDr...  Interventional   \n",
       "4                            Drug: Etripamil NS 70 mg  Interventional   \n",
       "5   Drug: AD-35 60mg groupDrug: AD-35 90mg groupDr...  Interventional   \n",
       "6                                      Drug: KBP-5074  Interventional   \n",
       "0   Drug: FEP-TAZ 4 gDrug: MeropenemDrug: ciproflo...  Interventional   \n",
       "1                  Drug: FT-4202/PlaceboDrug: FT-4202  Interventional   \n",
       "..                                                ...             ...   \n",
       "31                      Drug: TivantinibDrug: Placebo  Interventional   \n",
       "32                     Drug: AIC316Drug: Valacyclovir  Interventional   \n",
       "33  Drug: tivantinibDrug: omeprazoleDrug: s-warfar...  Interventional   \n",
       "34           Biological: MultiStemBiological: Placebo  Interventional   \n",
       "35                         Drug: VI-1121Drug: Placebo  Interventional   \n",
       "36  Drug: Diazoxide Choline Controlled-Release Tab...  Interventional   \n",
       "37                       Device: Amigo catheter robot  Interventional   \n",
       "38                       Drug: patiromerDrug: placebo  Interventional   \n",
       "39                         Drug: VI-0521Drug: Placebo  Interventional   \n",
       "40               Drug: Diazoxide cholineDrug: Placebo  Interventional   \n",
       "41     Drug: VI-0521Drug: topiramateDrug: phentermine  Interventional   \n",
       "42  Drug: VI-0521Drug: Placebo matched phentermine...  Interventional   \n",
       "43                                      Drug: VI-0521  Interventional   \n",
       "44                                Drug: SEL24/MEN1703  Interventional   \n",
       "45                  Drug: buprenorphineOther: Placebo  Interventional   \n",
       "46                    Drug: MLE4901 40mgDrug: Placebo  Interventional   \n",
       "47                       Drug: PyridorinDrug: Placebo  Interventional   \n",
       "48  Drug: GE-145 (AN113111) InjectionDrug: Visipaq...  Interventional   \n",
       "49            Drug: LGD-6972Drug: Placebo (Captisol®)  Interventional   \n",
       "50  Drug: Tyroserleutide for injection ,chemothera...  Interventional   \n",
       "51  Drug: Olive oil, 4gDrug: omega-3-carboxylic ac...  Interventional   \n",
       "52                           Drug: [18F] Flutemetamol  Interventional   \n",
       "53    Drug: Pyridoxamine DihydrochlorideDrug: Placebo  Interventional   \n",
       "54                     Drug: dalcetrapibDrug: Placebo  Interventional   \n",
       "55                     Drug: AH110690 (18F) Injection  Interventional   \n",
       "56                 Drug: Flutemetamol (18F) Injection  Interventional   \n",
       "57                                       Drug: GE-145  Interventional   \n",
       "58                        Drug: MBN-101Other: Placebo  Interventional   \n",
       "59  Drug: 75mg CXA-10Drug: 150mg CXA-10Other: Placebo  Interventional   \n",
       "60                                       Drug: CXA-10  Interventional   \n",
       "\n",
       "            Phases                              Sponsor/Collaborators  \\\n",
       "0          Phase 3                        WockhardtMedpace Finland OY   \n",
       "0          Phase 3                        WockhardtMedpace Finland OY   \n",
       "1          Phase 1              Forma Therapeutics, Inc.Medpace, Inc.   \n",
       "0          Phase 3                        WockhardtMedpace Finland OY   \n",
       "1          Phase 1              Forma Therapeutics, Inc.Medpace, Inc.   \n",
       "2          Phase 3                               AllecraMedpace, Inc.   \n",
       "0          Phase 3                        WockhardtMedpace Finland OY   \n",
       "1          Phase 1              Forma Therapeutics, Inc.Medpace, Inc.   \n",
       "2          Phase 3                               AllecraMedpace, Inc.   \n",
       "3          Phase 2                               AllecraMedpace, Inc.   \n",
       "0          Phase 3                        WockhardtMedpace Finland OY   \n",
       "1          Phase 1              Forma Therapeutics, Inc.Medpace, Inc.   \n",
       "2          Phase 3                               AllecraMedpace, Inc.   \n",
       "3          Phase 2                               AllecraMedpace, Inc.   \n",
       "4          Phase 3        Milestone Pharmaceuticals Inc.Medpace, Inc.   \n",
       "0          Phase 3                        WockhardtMedpace Finland OY   \n",
       "1          Phase 1              Forma Therapeutics, Inc.Medpace, Inc.   \n",
       "2          Phase 3                               AllecraMedpace, Inc.   \n",
       "3          Phase 2                               AllecraMedpace, Inc.   \n",
       "4          Phase 3        Milestone Pharmaceuticals Inc.Medpace, Inc.   \n",
       "5          Phase 2  Zhejiang Hisun Pharmaceutical Co. Ltd.Medpace,...   \n",
       "0          Phase 3                        WockhardtMedpace Finland OY   \n",
       "1          Phase 1              Forma Therapeutics, Inc.Medpace, Inc.   \n",
       "2          Phase 3                               AllecraMedpace, Inc.   \n",
       "3          Phase 2                               AllecraMedpace, Inc.   \n",
       "4          Phase 3        Milestone Pharmaceuticals Inc.Medpace, Inc.   \n",
       "5          Phase 2  Zhejiang Hisun Pharmaceutical Co. Ltd.Medpace,...   \n",
       "6          Phase 2                       KBP BiosciencesMedpace, Inc.   \n",
       "0          Phase 3                        WockhardtMedpace Finland OY   \n",
       "1          Phase 1              Forma Therapeutics, Inc.Medpace, Inc.   \n",
       "..             ...                                                ...   \n",
       "31         Phase 1                  Daiichi Sankyo, Inc.Medpace, Inc.   \n",
       "32         Phase 2     AiCuris Anti-infective Cures GmbHMedpace, Inc.   \n",
       "33         Phase 1                  Daiichi Sankyo, Inc.Medpace, Inc.   \n",
       "34         Phase 2                         Athersys, IncMedpace, Inc.   \n",
       "35         Phase 2                           VIVUS, Inc.Medpace, Inc.   \n",
       "36         Phase 2                     Essentialis, Inc.Medpace, Inc.   \n",
       "37  Not Applicable               Catheter Robotics, Inc.Medpace, Inc.   \n",
       "38         Phase 2                         Relypsa, Inc.Medpace, Inc.   \n",
       "39         Phase 3                           VIVUS, Inc.Medpace, Inc.   \n",
       "40         Phase 2                     Essentialis, Inc.Medpace, Inc.   \n",
       "41         Phase 3                           VIVUS, Inc.Medpace, Inc.   \n",
       "42         Phase 3                           VIVUS, Inc.Medpace, Inc.   \n",
       "43         Phase 3                           VIVUS, Inc.Medpace, Inc.   \n",
       "44  Phase 1Phase 2                Menarini GroupMedpace, Inc.Theradex   \n",
       "45         Phase 3    Braeburn PharmaceuticalsMedpace, Inc.Camurus AB   \n",
       "46         Phase 2    Millendo Therapeutics, Inc.Medpace, Inc.Covance   \n",
       "47         Phase 3  NephroGenex, Inc.Collaborative Study Group (CS...   \n",
       "48  Phase 1Phase 2             GE HealthcareMedpace, Inc.i3 Statprobe   \n",
       "49         Phase 1  Ligand PharmaceuticalsBeckloff Associates, Inc...   \n",
       "50         Phase 3  Shenzhen Kangzhe Pharmaceutical Co., Ltd.Fudan...   \n",
       "51         Phase 3  AstraZenecaOmthera Pharmaceuticals, IncMedpace...   \n",
       "52         Phase 3             GE Healthcarei3 StatprobeMedpace, Inc.   \n",
       "53         Phase 2  NephroGenex, Inc.Collaborative Study Group (CS...   \n",
       "54         Phase 3  DalCor PharmaceuticalsThe Montreal Health Inno...   \n",
       "55         Phase 2  GE Healthcarei3 StatprobeMedpace, Inc.Hvidovre...   \n",
       "56         Phase 3  GE HealthcareMedpace, Inc.i3 Statprobe(and 2 m...   \n",
       "57         Phase 2  GE Healthcarei3 StatprobeMedpace, Inc.(and 2 m...   \n",
       "58         Phase 2  Microbion CorporationUniversity of Pennsylvani...   \n",
       "59         Phase 2  Complexa, Inc.Clinical WorksMedpace, Inc.(and ...   \n",
       "60         Phase 2  Complexa, Inc.Kidney Research Network, formerl...   \n",
       "\n",
       "                     Funded Bys  \\\n",
       "0              Industry / Other   \n",
       "0              Industry / Other   \n",
       "1                      Industry   \n",
       "0              Industry / Other   \n",
       "1                      Industry   \n",
       "2                      Industry   \n",
       "0              Industry / Other   \n",
       "1                      Industry   \n",
       "2                      Industry   \n",
       "3                      Industry   \n",
       "0              Industry / Other   \n",
       "1                      Industry   \n",
       "2                      Industry   \n",
       "3                      Industry   \n",
       "4              Other / Industry   \n",
       "0              Industry / Other   \n",
       "1                      Industry   \n",
       "2                      Industry   \n",
       "3                      Industry   \n",
       "4              Other / Industry   \n",
       "5                      Industry   \n",
       "0              Industry / Other   \n",
       "1                      Industry   \n",
       "2                      Industry   \n",
       "3                      Industry   \n",
       "4              Other / Industry   \n",
       "5                      Industry   \n",
       "6                      Industry   \n",
       "0              Industry / Other   \n",
       "1                      Industry   \n",
       "..                          ...   \n",
       "31                     Industry   \n",
       "32                     Industry   \n",
       "33                     Industry   \n",
       "34                     Industry   \n",
       "35                     Industry   \n",
       "36                     Industry   \n",
       "37                     Industry   \n",
       "38                     Industry   \n",
       "39                     Industry   \n",
       "40                     Industry   \n",
       "41                     Industry   \n",
       "42                     Industry   \n",
       "43                     Industry   \n",
       "44                     Industry   \n",
       "45                     Industry   \n",
       "46                     Industry   \n",
       "47             Industry / Other   \n",
       "48                     Industry   \n",
       "49                     Industry   \n",
       "50             Other / Industry   \n",
       "51                     Industry   \n",
       "52                     Industry   \n",
       "53             Industry / Other   \n",
       "54             Industry / Other   \n",
       "55             Industry / Other   \n",
       "56                     Industry   \n",
       "57                     Industry   \n",
       "58  Industry / Other / U.S. Fed   \n",
       "59             Industry / Other   \n",
       "60             Industry / Other   \n",
       "\n",
       "                                        Study Results       ...        \\\n",
       "0   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "0   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "1   Allocation: RandomizedIntervention Model: Sequ...       ...         \n",
       "0   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "1   Allocation: RandomizedIntervention Model: Sequ...       ...         \n",
       "2   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "0   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "1   Allocation: RandomizedIntervention Model: Sequ...       ...         \n",
       "2   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "3   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "0   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "1   Allocation: RandomizedIntervention Model: Sequ...       ...         \n",
       "2   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "3   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "4   Intervention Model: Single Group AssignmentMas...       ...         \n",
       "0   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "1   Allocation: RandomizedIntervention Model: Sequ...       ...         \n",
       "2   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "3   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "4   Intervention Model: Single Group AssignmentMas...       ...         \n",
       "5   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "0   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "1   Allocation: RandomizedIntervention Model: Sequ...       ...         \n",
       "2   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "3   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "4   Intervention Model: Single Group AssignmentMas...       ...         \n",
       "5   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "6   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "0   Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "1   Allocation: RandomizedIntervention Model: Sequ...       ...         \n",
       "..                                                ...       ...         \n",
       "31  Allocation: Non-RandomizedIntervention Model: ...       ...         \n",
       "32  Allocation: RandomizedIntervention Model: Cros...       ...         \n",
       "33  Intervention Model: Sequential AssignmentMaski...       ...         \n",
       "34  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "35  Allocation: RandomizedIntervention Model: Cros...       ...         \n",
       "36  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "37  Intervention Model: Single Group AssignmentMas...       ...         \n",
       "38  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "39  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "40  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "41  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "42  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "43  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "44  Intervention Model: Single Group AssignmentMas...       ...         \n",
       "45  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "46  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "47  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "48  Allocation: Non-RandomizedIntervention Model: ...       ...         \n",
       "49  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "50  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "51  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "52  Allocation: Non-RandomizedIntervention Model: ...       ...         \n",
       "53  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "54  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "55  Intervention Model: Single Group AssignmentMas...       ...         \n",
       "56  Intervention Model: Single Group AssignmentMas...       ...         \n",
       "57  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "58  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "59  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "60  Allocation: RandomizedIntervention Model: Para...       ...         \n",
       "\n",
       "                                   Study Designs Other IDs  \\\n",
       "0                                     W-4282-301             \n",
       "0                                     W-4282-301             \n",
       "1                                   4202-HVS-101             \n",
       "0                                     W-4282-301             \n",
       "1                                   4202-HVS-101             \n",
       "2                                         AT-301             \n",
       "0                                     W-4282-301             \n",
       "1                                   4202-HVS-101             \n",
       "2                                         AT-301             \n",
       "3                                         AT-201             \n",
       "0                                     W-4282-301             \n",
       "1                                   4202-HVS-101             \n",
       "2                                         AT-301             \n",
       "3                                         AT-201             \n",
       "4                                  MSP-2017-1158             \n",
       "0                                     W-4282-301             \n",
       "1                                   4202-HVS-101             \n",
       "2                                         AT-301             \n",
       "3                                         AT-201             \n",
       "4                                  MSP-2017-1158             \n",
       "5                                Hisun-AD-35-003      ROAD   \n",
       "0                                     W-4282-301             \n",
       "1                                   4202-HVS-101             \n",
       "2                                         AT-301             \n",
       "3                                         AT-201             \n",
       "4                                  MSP-2017-1158             \n",
       "5                                Hisun-AD-35-003      ROAD   \n",
       "6                                  KBP5074-2-001  BLOCKCKD   \n",
       "0                                     W-4282-301             \n",
       "1                                   4202-HVS-101             \n",
       "..                                           ...       ...   \n",
       "31                                 ARQ197-A-U159             \n",
       "32                               AIC316-01-II-02             \n",
       "33                                 ARQ197-A-U158             \n",
       "34                                        B01-02             \n",
       "35                                        AD-201    AD-201   \n",
       "36                                         CT013             \n",
       "37                                   2008-001-01             \n",
       "38                                   RLY5016-202  PEARL-HF   \n",
       "39                                        OB-305             \n",
       "40                                         PC007             \n",
       "41                                        OB-301             \n",
       "42                                        OB-302             \n",
       "43                                        OB-303             \n",
       "44                                     CLI24-001             \n",
       "45                                     HS-16-555   CAM2038   \n",
       "46                     MLE4901-1012016-002179-91             \n",
       "47  PYR-3112014-001641-24CSG-17PYR-311 (PIONEER)   PIONEER   \n",
       "48                                    GE-145-001             \n",
       "49                                      L6972-01             \n",
       "50                            TYS-CN-1.1PUMP III             \n",
       "51                                    OM-EPA-004    ESPRIT   \n",
       "52                                    GE-067-015             \n",
       "53                                       PYR-210             \n",
       "54                                       DAL-301  dal-GenE   \n",
       "55                                        ALZ201    ALZ201   \n",
       "56                                    GE-067-005             \n",
       "57                                    GE 145-002             \n",
       "58                   MBN-101-201W81XWH-12-2-0100             \n",
       "59                                    CXA-10-301       PAH   \n",
       "60                                    CXA-10-204             \n",
       "\n",
       "            Start Date Primary Completion Date    Completion Date  \\\n",
       "0        July 25, 2019       December 25, 2020  December 25, 2020   \n",
       "0        July 25, 2019       December 25, 2020  December 25, 2020   \n",
       "1    December 11, 2018           December 2019      December 2019   \n",
       "0        July 25, 2019       December 25, 2020  December 25, 2020   \n",
       "1    December 11, 2018           December 2019      December 2019   \n",
       "2   September 24, 2018       November 30, 2019  December 30, 2019   \n",
       "0        July 25, 2019       December 25, 2020  December 25, 2020   \n",
       "1    December 11, 2018           December 2019      December 2019   \n",
       "2   September 24, 2018       November 30, 2019  December 30, 2019   \n",
       "3    September 5, 2017       February 14, 2018  February 14, 2018   \n",
       "0        July 25, 2019       December 25, 2020  December 25, 2020   \n",
       "1    December 11, 2018           December 2019      December 2019   \n",
       "2   September 24, 2018       November 30, 2019  December 30, 2019   \n",
       "3    September 5, 2017       February 14, 2018  February 14, 2018   \n",
       "4    December 10, 2018           December 2021      December 2021   \n",
       "0        July 25, 2019       December 25, 2020  December 25, 2020   \n",
       "1    December 11, 2018           December 2019      December 2019   \n",
       "2   September 24, 2018       November 30, 2019  December 30, 2019   \n",
       "3    September 5, 2017       February 14, 2018  February 14, 2018   \n",
       "4    December 10, 2018           December 2021      December 2021   \n",
       "5      October 4, 2018           July 31, 2019      July 31, 2020   \n",
       "0        July 25, 2019       December 25, 2020  December 25, 2020   \n",
       "1    December 11, 2018           December 2019      December 2019   \n",
       "2   September 24, 2018       November 30, 2019  December 30, 2019   \n",
       "3    September 5, 2017       February 14, 2018  February 14, 2018   \n",
       "4    December 10, 2018           December 2021      December 2021   \n",
       "5      October 4, 2018           July 31, 2019      July 31, 2020   \n",
       "6       April 25, 2018        October 31, 2019  December 12, 2019   \n",
       "0        July 25, 2019       December 25, 2020  December 25, 2020   \n",
       "1    December 11, 2018           December 2019      December 2019   \n",
       "..                 ...                     ...                ...   \n",
       "31           July 2012            January 2013           May 2013   \n",
       "32        October 2012                May 2013          July 2013   \n",
       "33       December 2011             August 2013     September 2013   \n",
       "34        October 2011              March 2015      December 2015   \n",
       "35         August 2011             August 2013        August 2013   \n",
       "36        October 2010          September 2011      December 2011   \n",
       "37           June 2010            October 2011       October 2011   \n",
       "38          April 2009           November 2009      December 2009   \n",
       "39       December 2008               June 2010          July 2010   \n",
       "40           June 2008            January 2009         March 2009   \n",
       "41       December 2007          September 2008     September 2008   \n",
       "42       November 2007                May 2009           May 2009   \n",
       "43       November 2007               June 2009          June 2009   \n",
       "44        January 2017           February 2019           May 2020   \n",
       "45      September 2016                May 2018       January 2019   \n",
       "46           July 2016          September 2017     September 2017   \n",
       "47           June 2014           December 2017         March 2018   \n",
       "48        October 2009           February 2010           May 2010   \n",
       "49       November 2013           February 2014         March 2014   \n",
       "50           July 2011              March 2013        August 2013   \n",
       "51         August 2011               June 2012          June 2012   \n",
       "52       December 2010              March 2011         April 2011   \n",
       "53         August 2008             August 2010        August 2010   \n",
       "54          April 2016             August 2020        August 2020   \n",
       "55      September 2008              March 2009      December 2009   \n",
       "56       December 2009            January 2014       January 2014   \n",
       "57       November 2010           December 2012      December 2012   \n",
       "58        January 2016       September 1, 2018  December 31, 2018   \n",
       "59      August 1, 2018             August 2019        August 2019   \n",
       "60      April 15, 2018               July 2019          July 2019   \n",
       "\n",
       "          First Posted Results First Posted  Last Update Posted  \\\n",
       "0      August 14, 2018    February 15, 2019                       \n",
       "0      August 14, 2018    February 15, 2019                       \n",
       "1     January 24, 2019     January 24, 2019                       \n",
       "0      August 14, 2018    February 15, 2019                       \n",
       "1     January 24, 2019     January 24, 2019                       \n",
       "2   September 27, 2018   September 28, 2018                       \n",
       "0      August 14, 2018    February 15, 2019                       \n",
       "1     January 24, 2019     January 24, 2019                       \n",
       "2   September 27, 2018   September 28, 2018                       \n",
       "3   September 21, 2018   September 21, 2018                       \n",
       "0      August 14, 2018    February 15, 2019                       \n",
       "1     January 24, 2019     January 24, 2019                       \n",
       "2   September 27, 2018   September 28, 2018                       \n",
       "3   September 21, 2018   September 21, 2018                       \n",
       "4      August 17, 2018    February 11, 2019                       \n",
       "0      August 14, 2018    February 15, 2019                       \n",
       "1     January 24, 2019     January 24, 2019                       \n",
       "2   September 27, 2018   September 28, 2018                       \n",
       "3   September 21, 2018   September 21, 2018                       \n",
       "4      August 17, 2018    February 11, 2019                       \n",
       "5      August 10, 2018     January 11, 2019                       \n",
       "0      August 14, 2018    February 15, 2019                       \n",
       "1     January 24, 2019     January 24, 2019                       \n",
       "2   September 27, 2018   September 28, 2018                       \n",
       "3   September 21, 2018   September 21, 2018                       \n",
       "4      August 17, 2018    February 11, 2019                       \n",
       "5      August 10, 2018     January 11, 2019                       \n",
       "6         July 2, 2018         July 2, 2018                       \n",
       "0      August 14, 2018    February 15, 2019                       \n",
       "1     January 24, 2019     January 24, 2019                       \n",
       "..                 ...                  ...                 ...   \n",
       "31     October 3, 2012    February 12, 2019                       \n",
       "32      August 7, 2012   September 23, 2016                       \n",
       "33    January 25, 2012    February 12, 2019                       \n",
       "34  September 19, 2011       August 2, 2016                       \n",
       "35   September 5, 2011    December 11, 2013                       \n",
       "36  September 30, 2010     January 10, 2014                       \n",
       "37        June 9, 2010       April 11, 2013      April 10, 2013   \n",
       "38      March 25, 2009    February 25, 2016   December 15, 2015   \n",
       "39   November 24, 2008   September 10, 2012     August 31, 2012   \n",
       "40       June 12, 2008     November 8, 2010                       \n",
       "41   November 26, 2007       March 30, 2015   September 3, 2012   \n",
       "42    November 6, 2007   September 10, 2012   September 6, 2012   \n",
       "43    November 6, 2007   September 10, 2012   September 6, 2012   \n",
       "44     January 2, 2017    December 12, 2018                       \n",
       "45    October 26, 2016        July 18, 2018                       \n",
       "46     August 15, 2016      October 2, 2017                       \n",
       "47        June 5, 2014        March 9, 2016                       \n",
       "48    October 30, 2009        April 5, 2012       April 4, 2012   \n",
       "49      August 9, 2013   September 25, 2014                       \n",
       "50    December 9, 2011    December 14, 2011                       \n",
       "51      August 3, 2011     December 5, 2014    December 5, 2014   \n",
       "52   December 23, 2010         July 2, 2013       June 21, 2013   \n",
       "53     August 14, 2008     October 28, 2015                       \n",
       "54     August 18, 2015    December 19, 2018                       \n",
       "55    November 5, 2008     December 7, 2009                       \n",
       "56    December 9, 2009   September 11, 2014  September 11, 2014   \n",
       "57    December 3, 2010      August 29, 2018         May 2, 2014   \n",
       "58         May 7, 2015      August 13, 2018                       \n",
       "59   February 28, 2018     January 11, 2019                       \n",
       "60    February 5, 2018     January 15, 2019                       \n",
       "\n",
       "                                            Locations Study Documents  \n",
       "0                                                                      \n",
       "0                                                                      \n",
       "1   Medpace Clinical Pharmacology UnitCincinnati, ...                  \n",
       "0                                                                      \n",
       "1   Medpace Clinical Pharmacology UnitCincinnati, ...                  \n",
       "2   St. Josephs Clinical ResearchAnaheim, Californ...                  \n",
       "0                                                                      \n",
       "1   Medpace Clinical Pharmacology UnitCincinnati, ...                  \n",
       "2   St. Josephs Clinical ResearchAnaheim, Californ...                  \n",
       "3   Kromerizska nemocniceKromeriz, CzechiaJahn Fer...                  \n",
       "0                                                                      \n",
       "1   Medpace Clinical Pharmacology UnitCincinnati, ...                  \n",
       "2   St. Josephs Clinical ResearchAnaheim, Californ...                  \n",
       "3   Kromerizska nemocniceKromeriz, CzechiaJahn Fer...                  \n",
       "4   Arizona Arrhythmia Research CenterPhoenix, Ari...                  \n",
       "0                                                                      \n",
       "1   Medpace Clinical Pharmacology UnitCincinnati, ...                  \n",
       "2   St. Josephs Clinical ResearchAnaheim, Californ...                  \n",
       "3   Kromerizska nemocniceKromeriz, CzechiaJahn Fer...                  \n",
       "4   Arizona Arrhythmia Research CenterPhoenix, Ari...                  \n",
       "5   Northern California ResearchSacramento, Califo...                  \n",
       "0                                                                      \n",
       "1   Medpace Clinical Pharmacology UnitCincinnati, ...                  \n",
       "2   St. Josephs Clinical ResearchAnaheim, Californ...                  \n",
       "3   Kromerizska nemocniceKromeriz, CzechiaJahn Fer...                  \n",
       "4   Arizona Arrhythmia Research CenterPhoenix, Ari...                  \n",
       "5   Northern California ResearchSacramento, Califo...                  \n",
       "6              MedpaceCincinnati, Ohio, United States                  \n",
       "0                                                                      \n",
       "1   Medpace Clinical Pharmacology UnitCincinnati, ...                  \n",
       "..                                                ...             ...  \n",
       "31  START - South Texas Accelerated Research Thera...                  \n",
       "32  Indiana University School of Medicine, IU Infe...                  \n",
       "33  START - South Texas Accelerated Research Thera...                  \n",
       "34  UCLA Medical CenterLos Angeles, California, Un...                  \n",
       "35  San Francisco, California, United StatesSanta ...                  \n",
       "36                                                                     \n",
       "37  Hoag Memorial Hospital PresbyterianNewport Bea...                  \n",
       "38  Investigator Site 029Miami, Florida, United St...                  \n",
       "39                                                                     \n",
       "40  National Research InstituteLos Angeles, Califo...                  \n",
       "41  Research SiteDurham, North Carolina, United St...                  \n",
       "42  Research SiteSan Diego, California, United Sta...                  \n",
       "43  Research SiteBirmingham, Alabama, United State...                  \n",
       "44  Northside HospitalAtlanta, Georgia, United Sta...                  \n",
       "45  Parkway Medical CenterBirmingham, Alabama, Uni...                  \n",
       "46  Hope Research Institute, LLCPhoenix, Arizona, ...                  \n",
       "47  CSG Investigational Site (#157)Birmingham, Ala...                  \n",
       "48  GE HealthcarePrinceton, New Jersey, United States                  \n",
       "49  Medpace Clinical PharmacologyCincinnati, Ohio,...                  \n",
       "50  Fudan University Zhongshan HospitalShanghai, S...                  \n",
       "51  Muscle Shoals, Alabama, United StatesChandler,...                  \n",
       "52  GE HealthcarePrinceton, New Jersey, United States                  \n",
       "53  The Collaborative Study GroupChicago, Illinois...                  \n",
       "54  Research SiteAlexander City, Alabama, United S...                  \n",
       "55                          GE HealthcareOslo, Norway                  \n",
       "56  GE HealthcarePrinceton, New Jersey, United States                  \n",
       "57  GE HealthcarePrinceton, New Jersey, United States                  \n",
       "58  Orthopedic Trauma Institute, University of Cal...                  \n",
       "59  University of AlabamaBirmingham, Alabama, Unit...                  \n",
       "60  Cedars Sinai Medical CenterLos Angeles, Califo...                  \n",
       "\n",
       "[1891 rows x 25 columns]"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_all_sponsors.head(5000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "df_all_sponsors.to_excel('etl_project_output.xlsx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
